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Abstract
Pathogens are significant selective forces on natural populations, and therefore genes and gene
regulators involved with combatting infections experience some of the strongest selection
pressures in the vertebrate genome. Studies in humans have used high-throughput next
generation sequencing to identify genes associated with infectious diseases, however, these
studies have been limited in wildlife systems despite their potential to improve public health,
agricultural production, and wildlife conservation. Anthrax is a globally distributed disease
caused by the virulent bacterial pathogen Bacillus anthracis, which has significant effects on
morbidity and mortality in humans, livestock, and wildlife populations. In this study, we utilize
whole genome sequencing to identify genetic loci associated with resistance to naturally
occurring B. anthracis infections in a plains zebra (Equus quagga) population of Etosha National
Park (ENP), Namibia. In ENP, anthrax is endemic and outbreaks occur annually in herbivorous
ungulates, with plains zebra contributing to the largest proportion of the observed anthrax
mortalities. We sequenced the genomes of 31 individuals who were exposed to anthrax but

survived (controls) and 27 individuals that died from B. anthracis infection (cases) during three
outbreak years (2008-2010). We used three tests to find genomic variants that were
differentiated between survivors and non-survivors, annotated the variants to genes, and
collected biological significance data to describe their putative roles in surviving anthrax
outbreaks. We also developed a novel weighting scheme for assessing the relative importance
of functional gene pathways associated with the identified gene set. The tests identified 8,522
variants that differed between the groups, of which 1,600 were in gene regions. As expected,
we found several genes (e.g., ANTXR2, KLRK1, MAP2Ks) associated with survival that were
previously described as involved with initial anthrax toxin entry, disruption, and immune
response. More surprisingly, we also found many genes that are more likely to either be
associated with behavior or late-stage systemic resistance to anthrax (e.g., GRIK1, JPH3,
CAMK2D), rather than to early or immunological resistance. We suggest that survival outcome
of endemic anthrax outbreaks in ENP stems from a wide array of phenotypes beyond an
individual’s immunological capacity. These GWAS results will be of interest to members of the
medical and veterinary fields as we confirmed previously reported genes of anthrax
pathogenesis and identified new genes that could have implications for the future development
of anthrax treatments and vaccines for both livestock and humans.

DEDICATION

For all the zebras that die of anthrax…
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WHOLE GENOME SEQUENCING REVEALS GENES AND PATHWAYS ASSOCIATED WITH
ANTHRAX SURVIVORSHIP IN PLAINS ZEBRA
Introduction
Pathogens are one of the strongest forces of natural selection shaping genetic and
phenotypic variability in the vertebrate kingdom. A host’s ability to withstand the harmful
effects of pathogen infections, whether it be morbidity or mortality, can stem from variation
across its genome that create differences in expression or the protein structure of translated
genes involved in immunity. Identifying genes associated with resistance is of interest to
scientists across many fields due to the potential for these data to be used for improving
human health, livestock production, and wildlife conservation.
Genome wide association studies (GWAS) are commonly employed in human
populations to identify genomic variants that increase or decrease the risk of disease
phenotypes. By 2018, at least 2,700 GWAS in humans had been conducted, but of these studies
less than 10% were aimed at identifying variants contributing towards infectious disease
phenotypes (Mozzi et al., 2018). Yet, it is important to conduct GWAS for infectious diseases
because these data can improve disease therapies and identify populations with greater risk
(Mozzi et al., 2018). Similar, identifying genomic variants associated with infectious disease
resistance in wildlife would benefit conservation biologists, evolutionary biologists, and disease
ecologists by providing data for improving wildlife health and understanding zoonotic disease
dynamics, but there are exceptionally few GWAS performed in wildlife-disease systems.
Until recently, it had been a challenge to pinpoint genes responsible for disease
resistance phenotypes, especially in wildlife. Prior to the rise of next generation sequencing
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technologies, wildlife studies used polymerase chain reaction (PCR) and Sanger sequencing to
primarily focus on the importance of immune genes, such as the Major Histocompatibility
Complex (MHC) and toll-like receptors (TLRs), in pathogen resistance phenotypes (for reviews
see Mukherjee et al., 2019; Spurgin & Richardson, 2010) due to their well-known roles in
recognizing pathogens and triggering immune responses. As the price of next generation
sequencing (NGS) technologies decrease and reference genomes become more feasible to
generate, more studies have used a targeted approach to incorporate additional immune genes
into studies examining the genetic determinants of disease resistance (Donaldson et al., 2018;
Elbers et al., 2018). However, employing a larger immune, candidate gene approach often does
not remove the same biases as PCR. To circumnavigate this problem, genome-wide RAD
sequencing have proven to be valuable for revealing genomic regions, beyond those with
known involvement in immune response, that are associated with resistance (Batley et al.,
2019; Cammen et al., 2015; Margres et al., 2018); for example, Gignoux-Wolfsohn et al., 2021.,
was able to capture critical loci associated with resistance to white nose syndrome that
exemplify the importance of hibernation behavior over immunological functioning in their
system that otherwise would not have been captured by targeting immune genes alone. While
RAD sequencing has the potential to identify regions associated with resistance, it is limited in
resolution in comparison to whole genome sequencing (WGS), which can lead to overlooking
gene variants important for disease resistance (Batley et al., 2021). For instance, Batley et al.
2021, applied a WGS GWAS and found an additional 294 protein coding genes, including 50
related to immune function, that were associated with dolphin morbillivirus infections; these
genes were overlooked in a previous RAD sequencing study of the same population (Batley et
2

al. 2019). Thus, to accurately describe the genetic determinants, and to relate their biological
significance to disease phenotypes, WGS approaches provide a powerful tool for wildlife
disease studies.
Identifying genes associated with disease resistance has implications for wildlife health
conservation, and GWAS results could be important for managing threatened and endangered
populations by working towards optimizing population’s long-term adaptive potential.
Emerging diseases pose threats to wildlife populations, for example chytridiomycosis is
challenging amphibian populations globally (Lips, 2016), chronic wasting disease is spreading in
North American deer (Rivera et al., 2019), and white nose syndrome is leading to declines in
hibernating bats (Frick et al., 2016). From previous works it is known that more inbred
populations can be at greater risk to these emerging diseases as host genetic diversity is
strongly correlated with the severity of disease phenotypes in individuals (DeCandia et al.,
2021), and with the severity of outbreaks in immunologically naïve wildlife populations
(Biedrzycka et al., 2020; Whiteman et al., 2006). Identifying genes associated with resistance to
emerging infectious diseases and recording genetic diversity could help predict population’s
resilience and response to disease epidemics and aid in creating more successful management
strategies that leverage the biological function of variants associated with disease phenotypes
(Byrne et al., 2021).
Studying wildlife in a natural setting will also provide valuable insights on the genetic
interactions between host and parasites and will contribute a deeper understanding of hostpathogen co-evolution and infectious disease dynamics. For example, for over 40 years
scientists have been tracking the evolution of resistance in rabbits and virulence in myxoma
3

virus, data that demonstrate an evolutionary arms race, such that measured host resistance
(Elfekih et al., 2021; Schwensow et al., 2017) and pathogen virulence phenotypes (Kerr et al.,
2017) appear to fluctuate asynchronously over time. Incorporating genomic data to this system
has allowed scientists to pinpoint the genetic sources of resistance evolution in rabbits (Alves et
al., 2019; Schwensow et al., 2020). Furthermore, scanning for genes associated with resistance
in natural settings provides an opportunity to examine the effects that confounding factors,
such as host demography, competition, pathogen strain diversity, and environmental
heterogeneity, have on host immunity and adaptation, which are often controlled for in
laboratory settings (Pedersen & Babayan, 2011). Consequently, there are often discrepancies
between field and laboratory studies on which genes contribute towards disease phenotypes
(Abolins et al., 2011; Schwensow et al., 2017; Turner & Paterson, 2013), but leveraging a
natural setting allows the identification of genes associated with a fitness advantage, in terms
of the protection against pathogens, while accounting for other interacting variables of an
ecosystem.
Bacillus anthracis is a highly virulent, bacterial pathogen that causes the disease
anthrax, which has negative implications for livestock, wildlife, and their closely linked human
populations. The pathogen is transmitted through the environment and requires host death for
onward transmission (Turner et al., 2014), which is a transmission mechanism that has likely
driven the evolution of high pathogen virulence. In the environment, B. anthracis takes on a
dormant, spore form that has high environmental plasticity, enabling it to persist in antipode
conditions, such as the hot plains of southern Africa versus the taiga in North America or Siberia
(Abolins et al., 2011; Schwensow et al., 2017; Turner & Paterson, 2013). In addition to locally
4

adapting to disparate environments, B. anthracis can adapt to different host communities as it
can infect a multitude of host species across the vertebrate kingdom (Hugh-Jones & de Vos,
2002), and also threatens some populations of endangered species (Hoffmann et al., 2017). In
addition, outbreaks of anthrax in humans are often linked to large outbreaks of sympatric
wildlife or livestock (Alexander et al., 2012). The greatest number of anthrax outbreaks,
however, are observed in wild and domestic ungulate species that encounter spores by
ingesting them through grazing or browsing (Carlson et al., 2019; Rao et al., 2019; Turner et al.,
2013). Due to the global impacts of this disease, a better understanding of the underlying
genetic factors that influence host resistance to anthrax could improve therapies and vaccines
for humans and livestock, as well as inform disease management strategies for anthraxendangered wildlife populations.
Etosha National Park (ENP) is an intriguing ecosystem for studying anthrax dynamics, as
anthrax outbreaks in the park are considered a natural part of the park’s ecology and occur in
annual cycles that primarily affect grazing and mixed-feeding herbivores (Lindeque & Turnbull,
1994). Surveillance and research on anthrax in the park reach back into the 1960s. Since then,
outbreaks in ENP during the wet season have consistently, and disproportionately affected
plains zebras (Equus quagga), while outbreaks in the dry season affect elephants (Ebedes, 1976;
Lindeque & Turnbull, 1994; Huang et al. in review). The carcasses infected with anthrax spores
may stimulate growth, quality, and productivity of vegetation in the surrounding area (Ganz et
al., 2014; Turner et al., 2014). In response, herbivores are attracted to these carcass-sites, feed
on the abundant supply of spores in the grass and soil, and presumably become infected with a
lethal dose of anthrax (Turner et al., 2016). However, after about 2 years, the concentration of
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spores in the soil decays to levels below lethal dosages, and these sites may transition to being
host vaccinator sites instead of killers. In ENP, between 52-87% of zebras tested positive for
anthrax antibodies, suggesting that not all individuals die from exposure to B. anthracis
(Cizauskas et al., 2014); sublethal exposures to the pathogen may be occurring at diluted
carcass sites where the spore concentrations fall below the lethal dose threshold (Turner et al.,
2016). In this study, we leverage the primary anthrax victims of ENP, plains zebra, in a GWAS to
identify genomic variants associated with surviving B. anthracis infections.
The salient contributory factors of anthrax virulence stem from three protein
components, or anthrax toxins, known as the protective antigen (PA), lethal factor (LF), and
edema factor (EF), which are encoded on B. anthracis plasmids. These proteins are so pivotal in
anthrax virulence that horizontal gene transfer of B. anthracis plasmids have extended
pathogenicity and virulence to other, typically benign, Bacillus species (Klee et al., 2010). They
are also critical because PA has a high affinity to two host receptors that are universally
expressed and highly conserved in vertebrate species, ANTXR1 and ANTXR2 (Dickson,
unpublished data). Once PA binds to these receptors, LT and EF can be endocytosed into host
cells where they disrupt the evolutionarily conserved MAPK (mitogen-activated protein kinase)
and PKA (protein kinase A) signaling pathways to first induce widespread apoptosis of immune
cells, followed by the cell death of cardiomyocytes, endothelial cells, and hepatocytes (Moayeri
et al., 2015).
Experimental studies have identified key genetic variants that confer resistance to
anthrax infections in model organisms. First, mice that do not express ANTXR2 on myeloid cells
are ubiquitously resistant to anthrax infections (Liu et al., 2009), and 11–24% of variation of
6

resistance in lymphocytes to toxins is explained by expression levels of ANTXR2 on cell surfaces
(Martchenko et al., 2012). These observations and high sequence conservation at this gene
across taxa imply that differential regulation of ANTXR2, as opposed to genetic sequence and
protein structure, could strongly contribute to variable resistance in natural populations.
Second, it was recently reported that polymorphisms at two HLA loci (MHC of humans)
increased survival in transgenic mice exposed to spores (Ascough et al., 2019). Third, variation
at the NLRP1 gene in mice governs how macrophages respond to intoxication of LF. Mice
macrophages with the NLRP1 sensitive allele (Nalp1bs) are vulnerable to cleavage by LF (Boyden
& Dietrich, 2006), and cleavage of this inflammasome protein induces the caspase-1-dependent
pathway to initiate apoptosis, or often referred to as pyroptosis (Fink et al., 2008).
Paradoxically, Nalp1bs mice are also more resistant to anthrax infections, because the cleavage
and respondent signaling pathways ignite a proinflammatory response to recruit immune cells
to the point of infection (Moayeri et al., 2010). A paralogous variant of the NLRP1 gene in rats
has a similar immunological effect when exposed to LF (Newman et al., 2010), but so far no
alleles in the NLRP1 ortholog of humans stimulate similar reactions. Thus, we hypothesize that
these or other genes or regulatory regions pertinent to anthrax infection establishment would
be associated with resistance to anthrax in a wildlife system.
In this thesis, we used WGS data to compile an assemblage of genomic variants
associated with surviving exposure to the virulent pathogen, B. anthracis, in an anthraxendemic wildlife system, Etosha National Park, by comparing the genomes of individuals that
survived (“controls”) with those that died (“cases”) of anthrax. The putative genes associated
with the identified variants were then investigated and hypotheses were generated regarding
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the biological underpinnings of heightened resistance to anthrax. We expect these results to
provide valuable data for guiding future work on the development of genetic applications to
manage anthrax disease in humans, livestock, and wildlife.
Methods
Study System
Etosha National Park (ENP), Namibia, is a large semi-arid savanna ecosystem with
distinct wet and dry seasons. The park is fenced and 22,915 km2 in area, and therefore
considered a semi-closed system that supports a diversity of wildlife species, of which plains
zebra (Equus quagga) are one of the most abundant in the park. In 2005, the estimated plains
zebra population size was approximately 15,000 individuals (EEI unpublished aerial data, 2005).
Anthrax is endemic in the park and is not actively managed (Lindeque, 1991), providing an ideal
natural system for studying host-pathogen evolution. Annual anthrax outbreaks in the park
tend to be localized in the center of the park, southwest of the Etosha Pan (Figure 1).

Figure 1. Map of Etosha National Park displaying locations of plains zebra cases and controls
Green dots represent the initial capture locations of plains zebra controls that survived previous
anthrax exposure, and red dots represent the locations of case samples that died from anthrax.
GPS data (not shown) and anti-PA serological titers indicated that control samples were both
exposed to anthrax but did not die over the time period that they were tracked, from 2008 to
2010.
8

Sample Collection
We obtained biological samples from zebra cases (anthrax mortalities) and controls
(anthrax exposed survivors) for a genome wide association study (GWAS) to identify genes
associated with susceptibility to anthrax. Cases and controls overlapped temporally and
spatially (Figure 1). Between 2008 and 2010, plains zebras were captured and collared with
either GPS or VHF collars for subsequent recaptures. The animal capture and handling
procedure was previously described by Cizauskas et al., 2015, and approved by the University of
California Berkeley’s Institutional Animal Care and Use Committee (IACUC), protocol no. R217‐
0509B (Berkeley, California, USA). During capture, sex was recorded and individuals were aged
by assessing tooth eruptions, caliper measurements of upper incisors, and wear patterns
(Smuts, 1974). Blood was collected from the peripheral vein into both
ethylenediaminetetraacetic acid (EDTA) and vacutainer tubes without anticoagulant for genetic
and serological analyses, respectively. EDTA blood and serum were stored at -20°C to -80°C
until further processing.
Of the zebra captured, we selected 31 individuals that “survived” three annual
outbreaks for whole genome sequencing (WGS), which served as our controls. Controls were
previously confirmed to have been exposed to anthrax by Cizauskas et al. 2014, using an
enzyme-linked immunosorbent assay (ELISA) that measured titers of antibodies against PA.
More specifically, we chose individuals that were positive in at least one capture by the
medium-conservative titer cut-off established in Cizauskas et al., 2014. For details on the age,
sex, initial capture dates, number of recaptures, and anti-ELISAs optical densities for all controls
see Appendix 1.1. The VHF or GPS collars confirm that these individuals survived past the 2010
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outbreak and stayed within the core region of ENP, where anthrax outbreaks occur annually in
zebra and the highest number of anthrax cases are observed.
Active surveillance for anthrax mortalities took place between 2008 and 2010 in central
ENP, as part of a study led by the University of California, Berkeley. During that time period, 325
zebra carcasses were found and diagnostic samples (blood, blood swabs) were collected to
confirm anthrax suspect cases by blood smears, bacterial culture and sequence confirmation of
plasmids pXO1 and pXO2 following protocols developed by Beyer et al., 2012. In addition, ear
tissue was collected from carcasses for host genetic analyses, when possible, and archived at 20°C until they were accessed for this study. Of the 325 carcasses, anthrax was confirmed as
the cause of death for 216 individuals. We randomly selected 27 of the ear tissues from these
confirmed cases for WGS.
DNA Extraction and Whole Genome Sequencing
DNA was extracted from the selected whole blood and carcass ear tissue samples using
Qiagen DNeasy blood and tissue kits (Qiagen Inc., Germantown, MD). Since mammalian red
blood cells are not nucleated, two to three extractions from each blood sample were
performed to obtain a minimum of 0.8 ug of genomic DNA. The quality and quantity of doublestranded DNA was determined using a Qubit 4 Fluorometer (Invitrogen, Waltham, MA), a
Nanodrop One UV-Vis Spectrophotometer (Thermo Fisher Scientific, Carlsbad, CA), and by
visualizing DNA extractions on a 1.5% agarose gel. Most samples, particularly the carcass
samples, had protein or salt contamination upon initial extraction, and therefore DNA was
purified using a AMPure XP magnetic bead protocol with a 0.5x bead to DNA ratio (Beckman
Coulter, Brea, CA). After performing DNA purifications, 31 whole blood and 27 carcass samples
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met the quality and quantity thresholds for WGS. DNA extractions from these samples were
sent to the BGI Group (Shenzhen, China) where 100bp paired-end libraries were prepared and
WGS was performed at 10X coverage using DNA nanoball sequencing (DNBseq) technology on a
BGISEQ-500 platform.
Bioinformatics
Low quality reads were filtered (quality score > 20) and adaptors were trimmed by the
BGI Genomics team. Filtered reads were aligned to the chromosome-length (2n =44) scaffolded
E. quagga genome obtained from the DNA Zoo Consortium (Dudchenko et al., 2017, 2018)
using the BWA-MEM command with default parameters from bwa v0.7.17 (Li & Durbin, 2009).
Variants on the 22 chromosomes and following 1,978 scaffolds were then joint-called using the
HaplotypeCaller, GenomicsDBImport, and GenotypeGVCFs functions of GATK v4.1.3 (Van der
Auwera & O’Connor, 2020) and subsequently hard filtered based on visual inspection with the
following parameters: quality by depth < 2.0, Fisher stand > 60.0, mapping quality < 50, strands
odds ratio > 3.0, mapping quality rank sum test < -2.5 & > 2.5, and read position rank sum test <
-2.5 & > 2.5. Further variant filtering was performed using vcftools and bcftools. In vcftools,
variants called in < 90% of individuals, with minor allele frequency (MAF) < 0.05, mapping
quality < 30, and mean site depth > 30 were removed. Following that, bcftools was used to
remove the following: multiallelic variants, SNPs within 5 bp of indels, and variants significantly
out of Hardy-Weinberg equilibrium (p < 1e-6). To check possible contamination in our samples,
we inspected expected/observed homozygosity and paired-wise relatedness using vcftools.
Consequently, we removed two samples from downstream analyses. Then, the vcf file
produced after filtering with GATK hard parameters, but before filtering with vcftools was used
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for GATK’s base quality score recalibration (BQSR) to adjust the quality scores of bam files for
systematic sequencing errors. Joint variant calling was repeated, excluding the contaminated
samples, on the BQSR bam files and the final vcf file was filtered using the same parameters in
GATK, vcftools, and bcftools as aforementioned.
Identifying SNPS Associated with Survival
Three methods were used to identify SNPs associated with survival. First, two GWAS
approaches – Chi-squared test and generalized linear model (GLM) – were utilized with the
GenABEL package (Aulchenko et al., 2007) in R v3.6.1 (R Core Team, 2021) to assess allele
frequency differences between cases and controls. Prior to running the GLM, we tested for
differences between age in the case versus control groups and determined that age was a
confounding factor to be considered as an exploratory variable. Given there was no significant
difference in age (p = 0.78), we excluded this variable in our GLM model. We did not include sex
in our model because there was a bias in sampling for females during the 2008-2010 capture
seasons that does not accurately reflect the population demographics. Due to this sex bias in
our sample, we excluded the HiC Scaffold 10 (also referred to here as chromosome 10) from
further analyses, because it was later determined to be the zebra X chromosome (see Results).
For the third method, we calculated Weir-Cockerham FST (Weir & Cockerham, 1984) between
cases and controls using vcftools (Danecek et al., 2011). If SNPs were significant in at least two
tests, those with p-values less than 0.001 in either GWAS test or that fell in the 99.95 percentile
of the FST distribution were selected for further annotation and investigation. We also
extrapolated the ‘top’ candidate genes by pulling the top 50 genes out for each test and then
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ranking these by accumulating their p-value rank from each test (i.e., the top gene has the
lowest sum).
Annotation of Candidate SNPs and Regions
We assigned all significant variants identified to genes by aligning the 50bp flanking
regions of these variants to the horse (Equus caballus) genome (EquCab3.0) using the blastn
function in BLAST 2.5.0+. In BLAST, the max_target_seqs parameter was set to one, and the
max_hsps parameter to three. Any variant that aligned to the reference genome more than
once was then discarded. The remaining variants and their flanking regions were converted into
a bed file according to their position in the horse genome. Using the bedtools intersect
function, we determined if any variant existed within a horse gene by assessing its position
relative to horse genes from the horse gff3 file. We incrementally set the distances of the SNPs
to genes by 0, 1,000, 5,000, and 10,000 base pairs (bp) to determine if variants were within,
upstream, or downstream from horse genes. In addition to using the BLAST approach, we used
the E. quagga buchelli genome annotation file and SnpEff to associate variants with predicted
zebra genes, similarly changing the -updown parameter from 0, 1,000, 5,000, and 10,000.
Finally, we compared the results of the BLAST and SnpEff approaches and retained variants that
had identical or similar (same protein family and function) calls in both. If the gene calls for a
variant were similar, but not identical, it was assigned the BLAST gene (see Appendix 2 for
code). In some cases, if the genes did not match but the zebra annotation was nearby (<
10,000bp), the gene was kept.
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Assessment of Gene Functions
We compiled data on the biological functions of genes identified that may play a role in
anthrax pathogenesis using DAVID 6.8 (Huang et al., 2009), including InterPro protein domains,
direct biological GO (gene ontology) terms, and KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathways. We opted to use direct biological GO terms, because it simplifies and
reduces redundancy in the analysis by excluding all of the parent terms. Function assessments
were first conducted on the top gene set and then on the entire dataset of genes with SNPs less
than 5,000 bp away. We viewed these data sets separately to determine if the top genes and
entire dataset were congruent, or if there were overrepresented biological functions associated
with the top genes. DAVID reports Fisher’s Exact Test p-values in addition to the false discovery
rate (FDR), Benjamini, and Bonferroni corrections (Šidák, 1967; Benjamini & Hochberg, 1995;
Benjamini & Hochberg, 2000).
Since genes can often be involved in or adjacent to multiple pathways, we used the KEGG
pathways dataset from all genes to perform a bimodal network analysis in R version 4.0 (R Core
Team, 2021). The intention of this analysis was to eliminate highly correlated or incidentally
appearing pathways and to highlight statistically non-significant pathways that had unique gene
entries. First, we removed any pathways describing infectious disease pathologies because
immune genes repeatedly appeared in these that would be eliminated later if we had not
removed these pathways. Then, we generated a bipartite network using the R package
ggnetwork (Wickham, 2009) where the genes were interpolated between multiple pathways if
it had multiple functions.
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We developed a weighting scheme to assess the significance of a particular pathway,
which involved weighting each pathway based on the number of genes associated with it and
how unique those genes in that pathway were compared to the entire data set. We used a
pathway’s eigen centrality as a proxy for its uniqueness, with the idea that if a pathway
consisted of genes from multiple other pathways, it would appear closer to the center of the
network and may be a false positive result. This would be counteracted, however, if a pathway
near the center of the network had many hits, since it would be less likely to be a false positive
if many genes from this pathway were appearing. This analysis also highlights pathways with
only a few, but highly unique genes. The following formula was used to weight the pathways:
Equation 1
𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝑃𝑃𝑃𝑃𝑃𝑃ℎ𝑤𝑤𝑤𝑤𝑤𝑤 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡 = #𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 ×
Results

− log(𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐)
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Bioinformatics
After removing low quality reads, a total of 21,505,045,763 reads remained (mean =
361,302,202 +- 1,8592,107) and the average coverage per sample was 13.97 +- 0.709 (Appendix
1.2). Following the first round of joint-genotyping, two samples were discarded because they
had abnormally high observed heterozygosity and relatedness to all the other samples
(Appendix 2), suggesting low sample quality (Marees et al., 2018). The final completion of joint
genotyping on the remaining 56 samples yielded 35,479,600 variants (32,025,877 SNPs and
3,607,039 indels). After filtering with GATK, vcftools, and bcftools 16,981,935 variants were left
(15,569,386 SNPs and 1,412,549 indels; Table 1).
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Table 1. Filtering criteria for the genome wide association analysis (GWAS) to identify variants
associated with resistance or susceptibility to anthrax in plains zebra
Parameter

Minor allele frequency > 0.05
Present in 90% of samples
Quality score < 30
Max average site depth
Hardy Weinberg Equilibrium
Remove SNPs near indels
Remove multiallelic SNPs

Setting

Variants Remaining

--maf 0.05
--max-missing 0.9
--minQ 30
--max-meanDP 30
--hwe 0.000001
--SnpGap 5:indel
-m2 -M2

35,479,600
17,644,861
17,493,015
17,493,015
17,467,112
17,151,314
16,981,935
16,981,935

Significant SNPs and their Associated Genes
A total of 12,371 variants (out of 16,981,935) were significant based on at least one of
the three different genome-wide association tests, when following our criteria of either p <
0.001 or greater than the 99.95 percentile of the FST distribution (FST > 0.167; Figure 2). Of
those, 8,522 variants (7,725 SNPs and 797 indels) were deemed significant in at least two tests
and 4,503 variants were significant in all three (Figure 2).
Of these 8,522 variants deemed significant in at least two tests, we identified 8,149
variants that aligned to the horse reference genome when running the 50bp flanking regions in
blastn; however, only 6,958 aligned only once to the horse genome. According to bedtools
intersect, 2,795 variants lie within 946 horse genes (147 in exons; 2,648 in introns), 84 lie within
1,000 bp of 69 horse genes, 284 lie within 5,000 bp of 185 horse genes, and 223 lie within
10,000 bp of 143 horse genes. After comparing the results between SnpEff and BLAST, we
retained 3,386 variants that were associated with 1,170 total genes. However, we chose to only
keep genes with variants at most 5,000 base pairs away from the 5’ UTR or 3’ UTR for the
remaining functional analyses (a total of 1,104 genes). The majority of the remaining SNPs were
in intergenic regions, which highlights the potential importance of gene regulation in
16

Figure 2. Venn Diagram (a) and Manhattan Plots (b) of single nucleotide polymorphism GWAS
results in plains zebras
(a) Venn diagram displaying the number of significant SNPs for each GWAS approach (GLM, ChiSquare, FST) and the number of SNPs significant in multiple tests. For each test, the total
number of significant SNPs are shown in parentheses. (b) Manhattan plots representing FST or
p-values (GLM, Chi-Square) for all SNPs examined across 22 zebra chromosomes. The red
horizontal lines represent the minimum thresholds (p-value = 0.001 or FST = 0.167), above which
significance was assigned to SNPs.
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disease resistance. Significant variants were distributed across all the 22 complete
chromosomes. However, chromosome 10 had the greatest number of SNPs, despite not being
the longest chromosome (Figure 3), with a larger than expected number of these SNPs aligning
to the horse X chromosome (320 out of 3,386). We believe that this is probably a result of
having a female-biased sample in our controls, in comparison to our cases. Thus, we discarded
the SNPs on chromosome 10 and excluded this chromosome from further analyses.
The GWAS detected several genes with well described roles in anthrax pathogenesis or
resistance (Table 2). Of genes that fell in the top gene set (n = 73 genes), only one of them,
EXOC6B, overlapped with those well described in the anthrax literature (Table 3). Of the

Figure 3. Distribution of significant SNPs across plains zebra chromosomes
Bar and line plot showing number of significant SNPs found on each fully assembled
chromosome (blue bars) and the length of each chromosome in base pairs (orange line).
Chromosome 10 was eliminated from further analyses since it was revealed to be the sex
chromosome; the number of significant SNPs on this chromosome greatly outweighs its length,
likely due to female-biased sampling in our dataset.
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Table 2. Anthrax pathogenesis or host resistance genes within which SNPs were found that
varied significantly between anthrax cases and controls in plains zebras
Genes listed (abbreviation and full name) were found by previous studies to either be
associated with host resistance or the invasion of the anthrax tripartite toxin (protective
antigen, lethal factor, edema factor) into host cells. The second column identifies genes that
varied between cases and controls in our study; if different, then the gene is either related to or
interacts with the gene in the first column. The third column provides the SNPs found within
the gene identified through the GWAS, and their scaffold positioning. The literature originally
describing the anthrax-associated gene function can be found in the last column.
Anthrax-associated
Gene
ANTXR2

anthrax toxin receptor 2

CDH5

Gene in this
GWAS
ANTXR2
CDH9

Cadherin-5

Cadherin-9

CASP1

Caspase-8

Caspase-1

CASP8

CASP10

Caspase-10

EXOC6

Exocyst Complex
Component 6

EXOC6

SNP Position and type

Literature

HiC_scaffold_3:89013845:Intron

(Scobie et al., 2003)

HiC_scaffold_9:96093397:Intron

(Warfel & D’Agnillo,
2011)

HiC_scaffold_4:130729801:Intron
HiC_scaffold_4:130730762:Intron
HiC_scaffold_4:130667547:Intron
HiC_scaffold_4:130667667:Intron
HiC_scaffold_4:130670117:Intron
HiC_scaffold_5:72302725:Intron
HiC_scaffold_5:72306466:Intron
HiC_scaffold_5:72306649:Intron
HiC_scaffold_5:72306732:Intron
HiC_scaffold_5:72307250:Intron
HiC_scaffold_5:72307356:Intron
HiC_scaffold_5:72307467:Intron
HiC_scaffold_5:72309664:Intron
HiC_scaffold_5:72310492:Intron
HiC_scaffold_5:72312563:Intron
HiC_scaffold_5:72313058:Intron
HiC_scaffold_5:72313210:Intron
HiC_scaffold_5:72314593:Intron
HiC_scaffold_5:72314605:Intron
HiC_scaffold_5:72318156:Intron
HiC_scaffold_5:72318549:Intron
HiC_scaffold_5:72318772:Intron
HiC_scaffold_5:72320949:Intron
HiC_scaffold_5:72321466:Intron
HiC_scaffold_5:72322597:Intron
HiC_scaffold_5:72322976:Intron
HiC_scaffold_5:72325763:Intron
HiC_scaffold_5:72326727:Intron
HiC_scaffold_5:72327922:Intron
HiC_scaffold_5:72328780:Intron
HiC_scaffold_5:72329530:Intron
HiC_scaffold_5:72329883:Intron
HiC_scaffold_5:72333217:Intron
HiC_scaffold_5:72333218:Intron
HiC_scaffold_5:72333787:Intron
HiC_scaffold_5:72335113:Intron
HiC_scaffold_5:72335277:Intron
HiC_scaffold_5:72336089:Intron
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(Cho et al., 2010; Fink
et al., 2008)

(Guichard et al., 2010)

Table 2. Continued

DQA
HLA genes

Major Histocompatibility
Complex II genes

DQB
DRB
KIF1C
Kinesin like protein

KIF1C
KLRK1

KLRK1
NKG2D type II integral
membrane protein

KLRD1

Natural killer cells
antigen CD94

KLRF1

MAP2K1/
MAP2K2/
MAP2K3/
MAP2K4/
MAP2K6/
MAP2K7

Mitogen-Activated
Protein Kinase Kinases

NTN1
Netrin-1

Killer cell lectin-like
receptor subfamily F
member 1

MAP2K3

HiC_scaffold_15:29676396:Upstream
HiC_scaffold_15:29674253:Intron
HiC_scaffold_15:29674081:Intron
HiC_scaffold_15:29673858:Intron
HiC_scaffold_15:29672895:Intron
HiC_scaffold_15:29672791:Intron
HiC_scaffold_15:29669405:Downstream
HiC_scaffold_15:29669401:Downstream
HiC_scaffold_15:29592019:Downstream
HiC_scaffold_15:29646191:Intron
HiC_scaffold_15:29644081:Intron
HiC_scaffold_15:29563478:Intron
HiC_scaffold_15:29563476:Intron
HiC_scaffold_15:29929034:Intron
HiC_scaffold_15:29929033:Intron
HiC_scaffold_11:64903009:Intron
HiC_scaffold_1:45710206:Downstream
HiC_scaffold_1:45709992:Downstream
HiC_scaffold_1:45708935:Downstream
HiC_scaffold_1:45707999:Downstream
HiC_scaffold_1:45784735:Intron
HiC_scaffold_1:45782394:Intron
HiC_scaffold_1:45779750:Exon
HiC_scaffold_1:45778189:Intron
HiC_scaffold_1:45775341:Intron
HiC_scaffold_1:45771772:Intron
HiC_scaffold_1:45769592:Intron
HiC_scaffold_1:45778650:Exon

(Ascough et al., 2019)

(McAllister et al., 2003;
Nakajima & Tanaka,
2010; Watters et al.,
2001)

(Joshi et al., 2009)

HiC_scaffold_1:46311921:Upstream

HiC_scaffold_11:53990210:Downstream
(Chopra et al., 2003)

MAP2K4
UNC5C

Netrin receptor
UNC5C
UNC5CL
Netrin receptor
UNC5C-like

DCC

Netrin receptor DCC

HiC_scaffold_11:60427363:Upstream
HiC_scaffold_3:76197050:Intron
HiC_scaffold_3:76302515:Intron
HiC_scaffold_3:76305272:Intron
HiC_scaffold_15:22829065:Exon
HiC_scaffold_9:22062728:Intron
HiC_scaffold_9:22058740:Intron
HiC_scaffold_9:22055156:Intron
HiC_scaffold_9:22052844:Intron
HiC_scaffold_9:22051816:Intron
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(Terra et al., 2011)

Table 2. Continued
PCDH7

Protocadherin 7

PCDH8

Protocadherin 8

PCDH17/
PCDHGC3/PCDH10
Protocadherins

PCDH9

Protocadherin 9

PCDH15

Protocadherin 15

PCDHAC2

Protocadherin alpha
C2

PCDHB7

Protocadherin Beta 7

MYLK3

Myosin light chain 3
NEDD4
NEDD4 E3 Ubiquitin
Protein Ligase

PGR

Progesterone

VCAM1

Vascular cell adhesion
protein 1

MYLK

Myosin light chain
kinase
NEDD4L
NEDD4 E3 Ubiquitin
Protein Ligase-like

PGR

VCAM1

HiC_scaffold_3:125362635:Intron
HiC_scaffold_3:125363128:Intron
HiC_scaffold_3:125364421:Intron
HiC_scaffold_3:125364450:Intron
HiC_scaffold_6:48632598:Intron
HiC_scaffold_6:37763895:Intron
HiC_scaffold_6:37761789:Intron
HiC_scaffold_6:37757489:Intron
HiC_scaffold_6:37757282:Intron
HiC_scaffold_6:37757021:Intron
HiC_scaffold_6:37756475:Intron
HiC_scaffold_6:37755927:Intron
HiC_scaffold_6:37754850:Intron
HiC_scaffold_6:37752863:Intron
HiC_scaffold_6:37752331:Intron
HiC_scaffold_6:37750329:Intron
HiC_scaffold_6:37748954:Intron
HiC_scaffold_6:37748155:Intron
HiC_scaffold_6:37746970:Intron
HiC_scaffold_6:37746306:Intron
HiC_scaffold_6:37746219:Intron
HiC_scaffold_6:37745618:Intron
HiC_scaffold_6:37744457:Intron
HiC_scaffold_6:37743090:Intron
HiC_scaffold_6:37740830:Intron
HiC_scaffold_6:37740723:Intron
HiC_scaffold_6:37739918:Intron
HiC_scaffold_6:37735107:Intron

(Bergman et al., 2005)

HiC_scaffold_2:132938481:Intron
HiC_scaffold_7:71826963:Intron
HiC_scaffold_7:71514446:3 Prime UTR
HiC_scaffold_4:23037810:Intron

(Warfel & D’Agnillo,
2011)

HiC_scaffold_9:17753625:Upstream

(Abrami et al., 2010)

HiC_scaffold_14:48614132:Intron
HiC_scaffold_14:48621035:Intron
HiC_scaffold_14:48621692:Intron
HiC_scaffold_14:48621998:Intron
HiC_scaffold_14:48624977:Intron
HiC_scaffold_14:48627130:Intron
HiC_scaffold_14:48627254:Intron
HiC_scaffold_14:48635291:Intron
HiC_scaffold_14:48638092:Intron

(Webster et al., 2003)

HiC_scaffold_18:33172498:3 Prime UTR
HiC_scaffold_18:33147440:3 Prime UTR

(Steele et al., 2005;
Warfel & D’Agnillo,
2008)
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Table 3. Biological information of highest ranked candidate genes
GO (Gene Ontology) were collected from DAVID and are colored by their position in Figure 6. Tissue and cell type specificity
information was gathered from the protein database.
Gene

Tissue Specificity (RNA)

Go terms

Tissue Specificity
(Protein)

Cell type enriched

junctophilin 3 (JPH3)

GO:0007612~learning, GO:0007613~memory,
GO:0035640~exploration behavior,
GO:0040011~locomotion, GO:0048168~regulation of
neuronal synaptic plasticity,
GO:0050885~neuromuscular process controlling
balance, GO:0060314~regulation of ryanodine-sensitive
calcium-release channel activity

Brain (all regions), detected
in many

NA

Horizontal cells, early
spermatids, bipolar
cells, cone
photoreceptors

desmoglein 1 (DSG1)

GO:0007156~homophilic cell adhesion via plasma
membrane adhesion molecules, GO:0050821~protein
stabilization

skin, tongue, detected in
some

Distinct membranous
expression in squamous
epithelia.
NA

Keratinocytes

thrombospondin type 1
domain containing 7B
(THSD7B)

Brain (pons and medulla),
epididymis, retina
Detected in many

radial spoke head 14
homolog (RSPH14)

Gse1 coiled-coil protein
(GSE1)
synaptotagmin 1 (SYT1)

Fallopian tube, testis,
Detected in many

GO:0006906~vesicle fusion GO:0017158~regulation of
calcium ion-dependent exocytosis,
GO:0048488~synaptic vesicle endocytosis,
GO:0048791~calcium ion-regulated exocytosis of
neurotransmitter, GO:0050806~positive regulation of
synaptic transmission, GO:0051966~regulation of
synaptic transmission, glutamatergic, GO:0098746~fast,
calcium ion-dependent exocytosis of neurotransmitter,
GO:1903861~positive regulation of dendrite extension
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Low specificity – Detected in
all
Brain (all regions), detected
in many

Expressed mainly in cilia
in fallopian tube,
endometrial glands and
respiratory epithelium.
Also expressed in male
tissues and squamous
epithelia.
General nuclear
expression in most tissues
Selective expression in
neuropil in CNS.

Horizontal cells, Rod
photoreceptor cells,
Cone photoreceptor
cells
Spermatids and
ciliated cells

Low tissue specificity
Bipolar cells, cone
photoreceptors, rod
photoreceptors,
Muller glia cells

Table 3. Continued
B-cell linker (BLNK)

Blood , lymphoid tissue,
detected in all

Low specificity – detected in
all
Low specificity – detected in
all

Distinct cytoplasmic
expression in lymphoid
tissues. Lower expression
observed in several other
tissues.
Membranous expression
in selected tissues,
including testis.
Ubiquitous cytoplasmic
expression with a granular
pattern
Selective nuclear
expression in female
reproductive system and
smooth muscle.
General nuclear
expression
Cytoplasmic expression in
most tissues

GO:0006349~regulation of gene expression by genetic
imprinting, GO:0006355~regulation of transcription,
DNA-templated, GO:0006357~regulation of
transcription from RNA polymerase II promoter,
GO:0007283~spermatogenesis, GO:0034773~histone
H4-K20 trimethylation, GO:0036124~histone H3-K9
trimethylation, GO:0045944~positive regulation of
transcription from RNA polymerase II promoter,
GO:0097368~establishment of Sertoli cell barrier
GO:0007018~microtubule-based movement

Low specificity – detected in
all

General nuclear
expression

Testis, detected in some

NA

Spermatids

GO:0007268~chemical synaptic transmission,
GO:0008344~adult locomotory behavior,
GO:0008543~fibroblast growth factor receptor signaling
pathway, GO:0010765~positive regulation of sodium ion
transport, GO:0050905~neuromuscular process

Adrenal gland, brain, heart
muscle, detected in many

NA

Cardiomyocytes

Elongin BC and Polycomb
repressive complex 2associated protein (EPOP)
cancer susceptibility
candidate 4 (CASC4)
progesterone receptor
(PGR)

Brain (all regions), detected
in many
Low specificity – detected in
all
GO:0006355~regulation of transcription, DNAtemplated, GO:0010629~negative regulation of gene
expression

Cervix, uterine,
endometrium, smooth
muscle, detected in many

Cysteine and histidine rich 1
(CYHR1-like)
Bardet-Biedl Syndrome
(BBS9)
AT-rich interaction domain
4B
(ARID4B)

dynein axonemal heavy
chain 8 (DNAH8)
fibroblast growth factor 12
(FGF12)
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B-cells, collecting
ducts

Trophoblast cells,
monocytes
Low specificity
Spermatids,
cardiomyocytes,
Leydig cells
Low specificity
Rod photoreceptor
cells, Cone
photoreceptor cells
Low specificity

Table 3. Continued

RRN3 homolog, RNA
polymerase I transcription
factor (RRN3)

CLPTM1 transmembrane
protein (CLPTM1)
regulator of G-protein
signaling 7 (RGS7)
leucine rich repeat
containing 58 (LRRC58)
solute carrier family 35
member F4 (SLC35F4)
guanylyl cyclase domain
containing 1 (GUCD1)
sex comb on midleg
homolog (SCMH1)
neurogenin 1 (NEUROG1)

GO:0001701~in utero embryonic development,
GO:0006361~transcription initiation from RNA
polymerase I promoter, GO:0007000~nucleolus
organization, GO:0007028~cytoplasm organization
,GO:0008283~cell proliferation, GO:0042254~ribosome
biogenesis, GO:0045893~positive regulation of
transcription, DNA-templated,
GO:0048872~homeostasis of number of cells,
GO:1902254~negative regulation of intrinsic apoptotic
signaling pathway by p53 class mediator,
GO:2000142~regulation of DNA-templated
transcription, initiation
GO:0033081~regulation of T cell differentiation in
thymus

Low specificity – detected in
all

Ubiquitous nucleolar
expression

Low specificity

Low specificity – detected in
all

Cytoplasmic expression in
most tissues

Low specificity

GO:0007186~G-protein coupled receptor signaling
pathway

Adrenal gland, brain

Brain specific expression

Horizontal cells,
bipolar cells

Detected in all

NA

Brain (cerebellum),
Detected in some

NA

Low specificity – detected in
all
Low specificity - Detected in
all

NA

Low cell type
specificity
Rod photoreceptor
cells, Early spermatids,
Cone photoreceptor
cells, Peritubular cells
Low specificity

NA

Spermatocytes

Brain (midbrain) and testis,
Detected in some

NA

Bipolar cells

GO:0006810~transport

GO:0006338~chromatin remodeling,
GO:0006355~regulation of transcription, DNAtemplated, GO:0007283~spermatogenesis,
GO:0009952~anterior/posterior pattern specification
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Table 3. Continued

cadherin EGF LAG sevenpass G-type receptor 1
(CELSR1)

Olfactory receptor family 7
subfamily A 270
pseudogene (OR7A270P)
calcium/calmodulin
dependent protein kinase II
delta (CAMK2D)

solute carrier family 2
member 1 (SLC2A1)

GO:0001764~neuron migration, GO:0001942~hair
follicle development, GO:0007156~homophilic cell
adhesion via plasma membrane adhesion molecules,
GO:0007266~Rho protein signal transduction,
GO:0007626~locomotory behavior,
GO:0009952~anterior/posterior pattern specification,
GO:0032956~regulation of actin cytoskeleton
organization, GO:0042060~wound healing,
GO:0042249~establishment of planar polarity of
embryonic epithelium, GO:0042472~inner ear
morphogenesis, GO:0045176~apical protein localization,
GO:0048105~establishment of body hair planar
orientation, GO:0060488~orthogonal dichotomous
subdivision of terminal units involved in lung branching
morphogenesis, GO:0060489~planar dichotomous
subdivision of terminal units involved in lung branching
morphogenesis, GO:0060490~lateral sprouting involved
in lung morphogenesis, GO:0090179~planar cell polarity
pathway involved in neural tube closure,
GO:0090251~protein localization involved in
establishment of planar polarity

Low specificity – detected in
many

NA

Alveolar epithelial
cells (lung), ciliated
cells (lung), club cells

NA

NA

NA

GO:0000082~G1/S transition of mitotic cell cycle,
GO:0003254~regulation of membrane depolarization,
GO:0006816~calcium ion transport
GO:0010613~positive regulation of cardiac muscle
hypertrophy, GO:0018105~peptidyl-serine
phosphorylation, GO:0018107~peptidyl-threonine
phosphorylation, GO:0046777~protein
autophosphorylation, GO:0051259~protein
oligomerization, GO:0060048~cardiac muscle
contraction, GO:0060341~regulation of cellular
localization, GO:1901897~regulation of relaxation of
cardiac muscle, GO:2000650~negative regulation of
sodium ion transmembrane transporter activity
GO:0006461~protein complex assembly,
GO:0042149~cellular response to glucose starvation

Low specificity – detected in
all

Cytoplasmic expression at
variable levels in selected
tissues, most abundant in
heart muscle.

Cardiomyocytes

Placenta
Detected in all

Cytoplasmic expression
most abundant in
endothelial and
trophoblastic cells.

Syncytiotrophoblasts,
Cytotrophoblasts,
Extravillous
trophoblasts
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Table 3. Continued

family with sequence
similarity 19 member A5, CC motif chemokine like
(FAM19A5/TAFA5)

Brain (all regions), detected
in many

cationic amino acid
transporter 4-like (SLC7A4)

Placenta, testis
Detected in many

Cytoplasmic expression in
several tissues, mainly in
brain and peripheral
nerves, gastrointestinal
mucosa, placenta and
gallbladder.
Cytoplasmic expression
mainly in testis and CNS.

Low specificity - Detected in
all

Ubiquitous nuclear
expression

Adrenal gland, brain (all
regions), retina

General cytoplasmic
expression

Intestine, liver, stomach,
detected in many

Cytoplasmic expression in
several tissues most
abundant in hepatocytes
and gastrointestinal tract.
Selective expression in a
few tissues, including
luminal membranous
expression in intestinal
tract.
General cytoplasmic
expression

metastasis associated 1
family member 2 (MTA2)

GO:0000122~negative regulation of transcription from
RNA polymerase II promoter, GO:0006306~DNA
methylation, GO:0043044~ATP-dependent chromatin
remodeling, GO:0045944~positive regulation of
transcription from RNA polymerase II promoter

glutamate ionotropic
receptor kainate type
subunit 1 (GRIK1)
dimethylaniline
monooxygenase [N-oxideforming] 5-like (FMO5-like)
acid sensing ion channel
subunit family member 5
(ASIC5)
dicer 1, ribonuclease III
(DICER1)

Intestine only

GO:0006309~apoptotic DNA fragmentation,
GO:0006396~RNA processing, GO:0030422~production
of siRNA involved in RNA interference,
GO:0030423~targeting of mRNA for destruction
involved in RNA interference, GO:0031054~pre-miRNA
processing, GO:0033168~conversion of ds siRNA to ss
siRNA involved in RNA interference, GO:0035087~siRNA
loading onto RISC involved in RNA interference,
GO:0035280~miRNA loading onto RISC involved in gene
silencing by miRNA
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Low specificity – detected in
all

Muller glia cells,
Bipolar cells,
Peritubular cells

Cytotrophoblasts,
Syncytiotrophoblasts,
Mucus-secreting cells,
Alveolar cells type 1,
granulocytes
Low specificity

Bipolar cells,
melanocytes,
spermatids
hepatocytes

Not detected

Low specificity

Table 3. Continued

ATPase secretory pathway
Ca2+ transporting 1
(ATP2C1)

adhesion G protein-coupled
receptor B1 (ADGRB1)
KIAA0319L
T-box 15 (TBX15)

GO:0006874~cellular calcium ion homeostasis ,
GO:0008544~epidermis development,
GO:0016339~calcium-dependent cell-cell adhesion via
plasma membrane cell adhesion molecules,
GO:0031532~actin cytoskeleton reorganization,
GO:0032468~Golgi calcium ion homeostasis,
GO:0043123~positive regulation of I-kappaB kinase/NFkappaB signaling

GO:0006351~transcription, DNA-templated,
GO:0048701~embryonic cranial skeleton morphogenesis

MAM domain containing
glycosylphosphatidylinositol
anchor 2 (MDGA2)
insulin like growth factor
binding protein 7 (IGFBP7)

protocadherin 9 (PCDH9)

Rho GTPase activating
protein 31 (ARHGAP31)

Low specificity – detected in
all

Ubiquitous cytoplasmic
expression with a granular
pattern

Low specificity

Brain (all regions)

NA

Horizontal cells

Low specificity – Detected in
all

Cytoplasmic expression
with granular pattern in
most tissues
Nuclear expression in
skeletal myocytes and a
subset of neuronal cells in
CNS
Cytoplasmic expression
mainly in Leydig cells

Low specificity

Plasma positivity in
several tissues.
Cytoplasmic expression
mainly in pancreatic islet
cells, renal tubules and
Leydig cells.
NA

Peritubular cells,
Leydig cells, Sertoli
cells

Liver, skeletal muscle,
tongue
Detected in many
Brain (all regions), testis
Detected in some
Low specificity - detected in
all

GO:0007156~homophilic cell adhesion via plasma
membrane adhesion molecules

Blood (all regions), brain,
detected in many

GO:0007264~small GTPase mediated signal transduction

Low specificity – Detected in
all

27

Cytoplasmic expression in
most tissues

Hepatocytes, smooth
muscle cells,
melanocytes, early
spermatids
Bipolar cells, early
spermatatids

Bipolar cells,
horizontal cells,
cardiomyocytes,
Muller glialcells
Endothelial cells,
macrophages, Ito cells

Table 3. Continued

ubiquitin like with PHD and
ring finger domains 2
(UHRF2)

COMM domain containing
10 (COMMD10)
neuronal modulator 1
(NOMO1)
MHC class I heavy chain
(EQMHCB2)

GO:0006511~ubiquitin-dependent protein catabolic
process, GO:0008283~cell proliferation,
GO:0010216~maintenance of DNA methylation,
GO:0016567~protein ubiquitination, GO:0030154~cell
differentiation, GO:0051865~protein autoubiquitination,
GO:0071158~positive regulation of cell cycle arrest,
GO:0090308~regulation of methylation-dependent
chromatin silencing

GO:0002474~antigen processing and presentation of
peptide antigen via MHC class I, GO:0006955~immune
response

Low specificity

NA

Low specificity

Low specificity - Detected in
all
Pancreas
Detected in many

Cytoplasmic expression in
several tissues
Cytoplasmic and
membranous expression
in most tissues.
Membranous expression
in most cell types
including epithelia and
endothelial cells. Highest
levels in monocytederived and lymphoid
cells.
Cytoplasmic and nuclear
expression in most
tissues.
Nuclear and cytoplasmic
expression at variable
levels in most cell types.
NA

Low tissue specificity

Low specificity – Detected in
all

solute carrier family 18
member B1 (SLC18B1)

Low specificity - Detected in
all

SET binding protein 1
(SETBP1)

Low specificity – Detected in
all

Cardiomyocytes
Monocytes

Hofbauer cells
Leydig cells,
peritubular cells

mediator complex subunit
20 (MED20)

GO:0006357~regulation of transcription from RNA
polymerase II promoter

Low specificity - Detected in
all

mutated in colorectal
cancers (MCC)

GO:0010633~negative regulation of epithelial cell
migration, GO:0045184~establishment of protein
localization, GO:0050680~negative regulation of
epithelial cell proliferation, GO:0090090~negative
regulation of canonical Wnt signaling pathway

Ovary, detected in many

Cytoplasmic expression in
most tissues

Bipolar cells, cone
photoreceptor cells,
hepatocytes

Testis only

Nuclear expression in a
subset spermatogonia.

Spermatids

doublesex and mab-3
related transcription factor
1 (DMRT1)
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Low specificity

Table 3. Continued

platelet derived growth
factor D (PDGFD)

lysine demethylase 4A
(KDM4A)

leucine rich repeat
containing 7 (LRRC7)
HECT domain and ankyrin
repeat containing E3
ubiquitin protein ligase 1
(HACE1)

GO:0007596~blood coagulation, GO:0008284~positive
regulation of cell proliferation, GO:0014068~positive
regulation of phosphatidylinositol 3-kinase signaling,
GO:0030335~positive regulation of cell migration,
GO:0031954~positive regulation of protein
autophosphorylation, GO:0043406~positive regulation
of MAP kinase activity,GO:0048008~platelet-derived
growth factor receptor signaling
pathway,GO:0050730~regulation of peptidyl-tyrosine
phosphorylation, GO:0070374~positive regulation of
ERK1 and ERK2 cascade, GO:0071230~cellular response
to amino acid stimulus
GO:0010507~negative regulation of autophagy,
GO:0014898~cardiac muscle hypertrophy in response to
stress, GO:0045892~negative regulation of transcription,
DNA-templated, GO:1900113~negative regulation of
histone H3-K9 trimethylation
GO:0007030~Golgi organization
,GO:0030334~regulation of cell migration,
GO:0042787~protein ubiquitination involved in
ubiquitin-dependent protein catabolic process,
GO:0061025~membrane fusion, GO:0070936~protein
K48-linked ubiquitination,

cortactin binding protein 2
(CTTNBP2)
unc-5 netrin receptor C
(UNC5C)
transmembrane channel
like 4 (TMC4)

GO:0007165~signal transduction, GO:0007420~brain
development, GO:0030334~regulation of cell migration,
GO:0033564~anterior/posterior axon guidance,
GO:0043065~positive regulation of apoptotic process
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Adrenal gland, detected in
many

Cytoplasmic expression in
several tissues, most
abundant in smooth
muscle cells. Additional
plasma positivity.

Cholangiocytes,
horizontal cells, Tcells, Ductal cells

Low specificity - Detected in
all

Cytoplasmic expression in
all tissues. Nuclear
expression in neuronal
cells and glandular cells of
fallopian tube.
NA

Low specificity

NA

Rod photoreceptors

Low specificity – detected in
many

General cytoplasmic
expression, including
neurons.

Brain (all regions), detected
in many

NA

Intestines, seminal vesicle

Cytoplasmic expression in
most glandular cells,
respiratory epithelia and
urothelial cells.

Granulocytes, Muller
Glial cells, Horizontal
cells, Cone
Photoreceptors
Leydig cells, Paneth
cells, Peritubular cells,
Rod photoreceptors,
Sertoli cells
Enterocytes, Paneth
cells

Brain (all regions) , detected
in many
Placenta Detected in all

Bipolar cells

Table 3. Continued

kelch like family member 32
(KLHL32)

sialic acid binding Ig like
lectin 15 (SIGLEC15)

phospholipase D family
member 5 (PLD5)
multivesicular body subunit
12B (MVB12B)
Heparan sulfateglucosamine 3sulfotransferase 3B1
(HS3ST3B1)
T cell receptor alpha
variable chain (TRAV)
Ras protein specific guanine
nucleotide releasing factor
2 (RASGRF2)
exocyst complex
component 6B (EXOC6B)
potassium voltage-gated
channel subfamily Q
member 3 (KCNQ3)

GO:0042787~protein ubiquitination involved in
ubiquitin-dependent protein catabolic process

Brain (all regions), fallopian
tube, detected in many

GO:0032956~regulation of actin cytoskeleton
organization, GO:0045124~regulation of bone
resorption, GO:0071402~cellular response to lipoprotein
particle stimulus, GO:2001204~regulation of osteoclast
development

Blood, detected in many

Cytoplasmic expression in
CNS, highly abundant in
astrocytes. Also
expression in motile cilia
in fallopian tube and
respiratory epithelia.
NA

Ciliated cells,
horizontal cells,
intestinal endocrine
cells

Brain (cerebellum), retina,
detected in many
Brain (all regions), detected
in all

NA

Spermatids, leydig
cells, horizontal cells
Kupffer cells

blood, liver, lymphoid tissue,
placenta, salivary gland
Detected in many

NA

NA

NA

GO:0007264~small GTPase mediated signal
transduction, GO:0035023~regulation of Rho protein
signal transduction

Brain (all regions), ovary
Detected in all

General cytoplasmic
expression

Cone photoreceptors,
extravillous
trophoblasts

GO:0006904~vesicle docking involved in exocytosis

Heart muscle
Detected in all
Brain (all regions), detected
in many

Nuclear and cytoplasmic
expression
NA

Cardiomyocytes

Salivary gland Detected in all

Nuclear expression in
most tissues

GO:0019075~virus maturation, GO:0042058~regulation
of epidermal growth factor receptor signaling pathway,
GO:0048524~positive regulation of viral process

SH3 domain binding
glutamate rich protein like
2 (SH3BGRL2)

30

NA

Hofbauer cells

Cone photoreceptor
cells, Ito cells,
Hepatocytes,
Syncytiotrophoblasts
NA

Alveolar cells type 2,
Bipolar cells, Exocrine
glandular cells,
Cardiomyocytes
Mucus secreting cells,
Paneth cells

Table 3. Continued

EYA transcriptional
coactivator and
phosphatase 4 (EYA4)
Laeverin (LVRN)

KIAA0556 ortholog
(KIAA0556)
Retroelement silencing
factor 1
(RESF1)
family with sequence
similarity 13 member C
(FAM13C)

GO:0006355~regulation of transcription, DNAtemplated, GO:0016576~histone dephosphorylation,
GO:0045739~positive regulation of DNA repair,
GO:2001240~negative regulation of extrinsic apoptotic
signaling pathway in absence of ligand
proteolysis, signal transduction, cell-cell signaling,
regulation of blood pressure, peptide catabolic process

Skeletal muscle
Detected in many

Cytoplasmic and nuclear
expression in most
tissues, including heart
and skeletal muscle

Collecting duct cells,
cardiomyocytes,
monocytes

Placenta, detected in some

Membrane expression in
placenta
Ubiquitous cytoplasmic
expression
NA

Early and late
spermatids
Low tissue specificity

Nuclear and/or
cytoplasmic expression in
most tissues, some also
show membranous
expression.

Sertoli cells, Ciliated
cells, Early spermatids

Low specificity - Detected in
all
NA
Low specificity – detected in
many
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NA

significant SNP and top gene results, the Chi Square and FST tests produced the most similar
results and differed from those identified through the GLM (Figures 2, 4), most likely because
the Chi Square and FST tests are both comparisons of differential abundances, whereas the GLM
is a statistical model that evaluates genetic variants as predictors. However, the top 10 genes
for each test were similar, and included JPH3, DSG1, THSD7B, RSPH14, GSE1, SYT1, BLNK, EPOP,
CASC4, and PGR (Figure 4).
Candidate Gene Functions
Our gene functionality analysis using the top genes (Figure 4) resulted in 18 genes
annotated with KEGG pathways (Figure 5) and 66 genes annotated with direct biological GO
terms (Table 3, Figure 6). However, no GO terms nor KEGG pathways were statistically
significant, suggesting that not one biological process dominates host resistance or the
modulation of survival outcome during B. anthracis infections in zebra. We also reported which
cells these genes are enriched in, according to the Human Protein Atlas, and found a variety of
expression profiles across these genes, which suggests there is not one specific cell or organtype most highly involved in overcoming infection (Table 3).
Next, we inputted all the genes (n = 1,104) that either contained or were nearby
significant SNPs (less than 5000 bp away) into DAVID and extrapolated InterPro domains, KEGG
pathways, and direct biological GO terms. Of the KEGG pathways, 38 were statistically
significant by Fisher’s Exact test (Figure 7), but only one was statistically significant with
Bonferroni correction (‘Axon guidance’). We weighted the KEGG Pathways using a network
analysis to emphasize pathways with a larger assortment of unique genes and less pleiotropy.
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Figure 4. Heat map showing top genes identified from GWAS tests in plains zebras
Genes listed were amongst the top 50 cumulatively ranked genes with or within 10,000 bp of a
SNP significantly differentiated in at least one of the three GWAS tests (Chi-Square, FST, GLM)
between plains zebra cases and controls. SNPs that were more than 10,000 base pairs from a
gene were omitted. Darker bars indicate a higher ranking and white bars indicate the gene did
not appear in the top 50. The genes are ordered by their sum ranks, genes with the highest
cumulative rank are towards the top, indicating greater importance.
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Figure 5. KEGG Pathways of the highest ranked candidate genes
Eighteen of the top candidate genes (black dots, right side) were associated with (grey lines)
KEGG pathways (colored dots, left side). KEGG pathways with darker color and larger size had
two genes and pathways with smaller dots and lighter color had only one gene.
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Figure 6. KEGG and Biological Gene Ontology analysis of the highest ranked candidate genes
Revigo TreeMap of biological GO terms. REVIGO organized the ontology terms into colored squares using the default, SimRel
method. The larger the square, the more genes reported with that ontology term.
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Figure 7. Bar plot of KEGG Pathways using all genes from the GWAS in plains zebras
KEGG pathways are listed based on their similarity to other pathways, indicated by the topology
and branch lengths in the dendrogram. Horizontal bars represent the number of genes found in
the GWAS that belong to a given pathway, with the color gradient indicating the Fold
Enrichment score reported in DAVID. Pathways that were significant by Fisher’s Exact Test are
in bold, but only one remained significant after Bonferroni correction (‘Axon guidance’).
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The statistically significant pathways that remained after the network analysis were:
‘Cell adhesion molecules’, ‘Neuroactive ligand-receptor interaction’, ‘Antigen processing and
presentation’, ‘Axon guidance’, ‘Adherens junction’, ‘Regulation of actin cytoskeleton’, ‘MAPK
signaling’, ‘Focal adhesion’, ‘Inositol phosphate metabolism’, ‘Arrythmogenic right ventricular
cardiomyopathy’, and Fc gammp R-mediated phagocytosis’ (Figure 8). Again, our GO term
analysis revealed no statistically significant GO terms after Bonferroni correction, but we report
those significant before correction using Fisher’s Exact Test in Table 4 and 5. The identified GO
terms, KEGG Pathways, and InterPro domains were associated with a wide array of biological
functioning, which further suggests that anthrax resistance is multifaceted and involves
multiple physiological processes that go beyond those involved in immune response.
To synthesize our results, we created a Venn diagram that classifies some of the top
genes identified through the GWAS, KEGG pathways, GO terms, and protein domains into
broader categories of how they may contribute to anthrax survival (Figure 9). In general, we
found terms that were associated with the universally expressed, targeted pathways of anthrax
pathogenesis (e.g., MAPK signaling pathway). We also identified genes and terms that were
unrelated to immune response or the well-known anthrax pathways, but were instead linked to
behavior, immune processes, and systemic processes.
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Figure 8. KEGG pathways after extracting terms based on number of genes and uniqueness
(top) Network analysis showing connections between genes (black dots), and KEGG pathways
(colored dots) with the size of the dot is the weight calculated by Equation 1. Only pathways
greater than a weight of two are shown. The number reflects the relative ranking of pathways
from highest weight to lowest, and corresponds to pathways shown in the bottom panel.
(bottom) The number of genes found in each KEGG pathway with a weight greater than 2. The
number corresponds to its weight rank and the color with its position in top figure. The size of
circle indicates its fold enrichment. Bolded terms were significant by Fisher’s exact test.
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Table 4. Top biological GO terms hits using all genes identified by the GWAS
All terms had a p-value of less than 0.1. No terms remained significant following Bonferroni (Šidák, 1967), Benjamini (Benjamini &
Hochberg, 1995), and FDR (Benjamini & Hochberg, 2000) corrections for multiple testing.
# of
Genes

P-Value

Fold Enrichment

Bonferroni

Benjamini

FDR

GO:0002504~antigen processing and presentation of peptide or
polysaccharide antigen via MHC class II

5

0.00291

7.64

0.998

1.000

1.000

GO:0035385~Roundabout signaling pathway

4

0.00364

11.21

1.000

1.000

1.000

GO:0030335~positive regulation of cell migration

15

0.00695

2.23

1.000

1.000

1.000

GO:0030036~actin cytoskeleton organization

11

0.00801

2.64

1.000

1.000

1.000

GO:0007165~signal transduction
GO:0007156~homophilic cell adhesion via plasma membrane adhesion
molecules
GO:0098911~regulation of ventricular cardiac muscle cell action
potential
GO:0014068~positive regulation of phosphatidylinositol 3-kinase
signaling
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0.00859

1.61

1.000

1.000

1.000

12

0.00890

2.46

1.000

1.000

1.000

4

0.00932

8.40

1.000

1.000

1.000

9

0.00979

2.96

1.000

1.000

1.000

GO:0006351~transcription, DNA-templated

23

0.01329

1.73

1.000

1.000

1.000

GO:0050885~neuromuscular process controlling balance

8

0.01596

2.98

1.000

1.000

1.000

GO:0033138~positive regulation of peptidyl-serine phosphorylation

9

0.01687

2.70

1.000

1.000

1.000

GO:0051764~actin crosslink formation

4

0.01828

6.72

1.000

1.000

1.000

GO:0007214~gamma-aminobutyric acid signaling pathway

5

0.01935

4.67

1.000

1.000

1.000

GO:0010811~positive regulation of cell-substrate adhesion

6

0.01977

3.73

1.000

1.000

1.000

GO:0051480~regulation of cytosolic calcium ion concentration

5

0.02339

4.42

1.000

1.000

1.000

GO:0030225~macrophage differentiation
GO:0035584~calcium-mediated signaling using intracellular calcium
source

4

0.02404

6.11

1.000

1.000

1.000

4

0.02404

6.11

1.000

1.000

1.000

GO:0030336~negative regulation of cell migration

9

0.02703

2.48

1.000

1.000

1.000

GO:0030534~adult behavior

5

0.02790

4.20

1.000

1.000

1.000

GO:0050891~multicellular organismal water homeostasis

3

0.03123

10.08

1.000

1.000

1.000

GO:0090557~establishment of endothelial intestinal barrier

3

0.03123

10.08

1.000

1.000

1.000

Term

39

Table 4. Continued
GO:0055012~ventricular cardiac muscle cell differentiation

3

0.03123

10.08

1.000

1.000

1.000

GO:0060972~left/right pattern formation

3

0.03123

10.08

1.000

1.000

1.000

GO:0051901~positive regulation of mitochondrial depolarization

3

0.03123

10.08

1.000

1.000

1.000

GO:0001570~vasculogenesis

7

0.03632

2.80

1.000

1.000

1.000

GO:0007631~feeding behavior

5

0.03838

3.82

1.000

1.000

1.000

GO:0055078~sodium ion homeostasis

3

0.04502

8.40

1.000

1.000

1.000

GO:0042297~vocal learning

3

0.04502

8.40

1.000

1.000

1.000

GO:0007613~memory

6

0.04857

2.96

1.000

1.000

1.000

GO:0051017~actin filament bundle assembly

5

0.05081

3.50

1.000

1.000

1.000

GO:0051965~positive regulation of synapse assembly

7

0.05325

2.55

1.000

1.000

1.000

GO:0008045~motor neuron axon guidance

4

0.05559

4.48

1.000

1.000

1.000

GO:0007416~synapse assembly

5

0.05775

3.36

1.000

1.000

1.000

GO:0007612~learning

5

0.06518

3.23

1.000

1.000

1.000

GO:0050770~regulation of axonogenesis

4

0.06551

4.20

1.000

1.000

1.000

GO:0030032~lamellipodium assembly

5

0.07307

3.11

1.000

1.000

1.000

GO:0090307~mitotic spindle assembly

5

0.07307

3.11

1.000

1.000

1.000

GO:0051496~positive regulation of stress fiber assembly

5

0.07307

3.11

1.000

1.000

1.000

GO:0045663~positive regulation of myoblast differentiation

4

0.07616

3.95

1.000

1.000

1.000

GO:0055007~cardiac muscle cell differentiation

4

0.07616

3.95

1.000

1.000

1.000

GO:0001508~action potential
GO:0045954~positive regulation of natural killer cell mediated
cytotoxicity

3

0.07769

6.30

1.000

1.000

1.000

3

0.07769

6.30

1.000

1.000

1.000

GO:0009791~post-embryonic development

8

0.07869

2.13

1.000

1.000

1.000

GO:0010976~positive regulation of neuron projection development

6

0.08627

2.52

1.000

1.000

1.000

GO:0008104~protein localization

6

0.08627

2.52

1.000

1.000

1.000

GO:0050919~negative chemotaxis

4

0.08752

3.73

1.000

1.000

1.000

GO:0042384~cilium assembly

10

0.09525

1.82

1.000

1.000

1.000

GO:0060088~auditory receptor cell stereocilium organization

3

0.09606

5.60

1.000

1.000

1.000

40

Table 4. Continued
GO:0046328~regulation of JNK cascade

3

0.09606

5.60

1.000

1.00

1.00

GO:1901214~regulation of neuron death

3

0.09606

5.60

1.000

1.00

1.00

GO:0050766~positive regulation of phagocytosis

4

0.09955

3.54

1.000

1.00

1.00

Table 5. Top biological InterPro hits using all genes identified by the GWAS
All terms had a p-value of less than 0.1. Bolded terms remained significant following both Benjamini and FDR corrections for multiple
testing.
Interpro Term

# of Genes

P-Value

Fold
Enrichment

Bonferroni

Benjamini

FDR

EGF-like, conserved site

26

3.561E-06

2.86

4.750E-03

4.086E-03

4.019E-03

Epidermal growth factor-like domain

28

6.157E-06

2.65

8.198E-03

4.086E-03

4.019E-03

EGF-like calcium-binding

20

9.168E-06

3.26

0.012

4.086E-03

4.019E-03

Extracellular ligand-binding receptor

11

1.282E-05

5.65

0.017

4.286E-03

4.216E-03

EGF-like calcium-binding, conserved site

17

1.669E-05

3.56

0.022

4.371E-03

4.299E-03

EGF-type aspartate/asparagine hydroxylation site

17

1.962E-05

3.51

0.026

4.371E-03

4.299E-03

Pleckstrin homology domain

30

3.316E-05

2.33

0.043

6.334E-03

6.230E-03

NMDA receptor

7

8.217E-05

8.47

0.104

0.011

0.0108

Ionotropic glutamate receptor

7

8.217E-05

8.47

0.104

0.011

0.0108

Glutamate receptor, L-glutamate/glycine-binding

7

8.217E-05

8.47

0.104

0.011

0.0108

IQ motif, EF-hand binding site

14

1.961E-04

3.39

0.231

0.024

0.0234

Ion transport domain

16

3.321E-04

2.92

0.359

0.037

0.0364

Immunoglobulin-like fold

50

9.251E-04

1.61

0.710

0.095

0.0936

Immunoglobulin I-set

17

1.142E-03

2.51

0.783

0.100

0.0988

Protein kinase, ATP binding site

32

1.328E-03

1.83

0.831

0.100

0.0988

Pleckstrin homology-like domain

36

1.330E-03

1.76

0.831

0.100

0.0988

EF-hand-like domain

27

1.576E-03

1.94

0.879

0.100

0.0988
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Table 5. Continued
Immunoglobulin subtype 2

21

1.838E-03

2.14

0.915

0.100

0.0988

RyR/IP3R Homology associated domain

4

1.865E-03

13.56

0.918

0.100

0.0988

Dynein heavy chain

5

1.890E-03

8.47

0.920

0.100

0.0988

Dynein heavy chain, P-loop containing D4 domain

5

1.890E-03

8.47

0.920

0.100

0.0988

MIR motif

5

1.890E-03

8.47

0.920

0.100

0.0988

Dynein heavy chain, coiled coil stalk

5

1.890E-03

8.47

0.920

0.100

0.0988

Dynein heavy chain domain

5

1.890E-03

8.47

0.920

0.100

0.0988

Dynein heavy chain, domain-2

5

1.890E-03

8.47

0.920

0.100

0.0988

Protein kinase-like domain
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1.954E-03

1.61

0.927

0.100

0.0988

MHC class II, alpha/beta chain, N-terminal

5

2.832E-03

7.70

0.977

0.140

0.1379

Sterile alpha motif/pointed domain

15

3.387E-03

2.42

0.989

0.154

0.1513

Intracellular calcium-release channel

4

3.567E-03

11.30

0.992

0.154

0.1513

Inositol 1,4,5-trisphosphate/ryanodine receptor

4

3.567E-03

11.30

0.992

0.154

0.1513

Ryanodine receptor-related

4

3.567E-03

11.30

0.992

0.154

0.1513

Immunoglobulin-like domain

36

4.165E-03

1.64

0.996

0.174

0.1712

Protein kinase, catalytic domain

40

4.603E-03

1.58

0.998

0.187

0.1834

Laminin G domain

9

5.711E-03

3.25

1.000

0.225

0.2209

Dedicator of cytokinesis C-terminal

4

9.136E-03

8.47

1.000

0.321

0.3161

DHR-1 domain

4

9.136E-03

8.47

1.000

0.321

0.3161

DHR-2 domain

4

9.136E-03

8.47

1.000

0.321

0.3161

Dedicator of cytokinesis

4

9.136E-03

8.47

1.000

0.321

0.3161

PLC-like phosphodiesterase, TIM beta/alpha-barrel domain

6

9.724E-03

4.42

1.000

0.326

0.3204

Peptidase M2, peptidyl-dipeptidase A

3

0.0100

16.95

1.000

0.326

0.3204

Sterile alpha motif domain

12

0.0101

2.42

1.000

0.326

0.3204

PDZ domain

16

0.0102

2.07

1.000

0.326

0.3204

Fibronectin, type III

19

0.0122

1.88

1.000

0.378

0.3716

Na+ channel, amiloride-sensitive

4

0.0131

7.53

1.000

0.398

0.3918

Myosin head, motor domain

7

0.0134

3.49

1.000

0.399

0.3922
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Table 5. Continued
Serine-threonine/tyrosine-protein kinase catalytic domain

15

0.0144

2.05

1.000

0.416

0.4096

Cadherin conserved site

9

0.0146

2.77

1.000

0.416

0.4096

Concanavalin A-like lectin/glucanase, subgroup

18

0.0167

1.86

1.000

0.465

0.4576

C2 calcium-dependent membrane targeting

16

0.0191

1.92

1.000

0.514

0.5056

Protocadherin

3

0.0192

12.71

1.000

0.514

0.5056

Cadherin

9

0.0217

2.59

1.000

0.570

0.5601

3'5'-cyclic nucleotide phosphodiesterase

5

0.0228

4.46

1.000

0.583

0.5729

Protein-tyrosine/Dual specificity phosphatase

10

0.0231

2.39

1.000

0.583

0.5729

Cadherin-like

9

0.0260

2.50

1.000

0.645

0.6343

3'5'-cyclic nucleotide phosphodiesterase, conserved site

5

0.0272

4.24

1.000

0.662

0.6515

Protein-tyrosine phosphatase, active site

9

0.0284

2.46

1.000

0.679

0.6674

Tyrosine-protein kinase, catalytic domain

10

0.0294

2.29

1.000

0.689

0.6772

Neurotransmitter-gated ion-channel transmembrane domain

7

0.0317

2.89

1.000

0.704

0.6927

Neurotransmitter-gated ion-channel, conserved site

7

0.0317

2.89

1.000

0.704

0.6927

BTB/Kelch-associated

8

0.0319

2.61

1.000

0.704

0.6927

3'5'-cyclic nucleotide phosphodiesterase, catalytic domain

5

0.0321

4.04

1.000

0.704

0.6927

C-type lectin

9

0.0336

2.38

1.000

0.725

0.7128

Neurotransmitter-gated ion-channel ligand-binding

7

0.0352

2.82

1.000

0.736

0.7241

Neurotransmitter-gated ion-channel

7

0.0352

2.82

1.000

0.736

0.7241

Gamma-aminobutyric acid A receptor

5

0.0375

3.85

1.000

0.752

0.7392

HD/PDEase domain

5

0.0375

3.85

1.000

0.752

0.7392

Protein-tyrosine phosphatase, receptor/non-receptor type

6

0.0377

3.18

1.000

0.752

0.7392

Kelch repeat type 1

8

0.0382

2.51

1.000

0.752

0.7392

WW domain

7

0.0390

2.76

1.000

0.756

0.7432

MHC class II, beta chain, N-terminal

3

0.0444

8.47

1.000

0.836

0.8225

Dynein heavy chain, domain-1

3

0.0444

8.47

1.000

0.836

0.8225

Insulin-like growth factor binding protein, N-terminal

12

0.0476

1.92

1.000

0.885

0.8702

Kelch-like protein, gigaxonin

6

0.0526

2.91

1.000

0.964

0.9482
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Table 5. Continued
Armadillo-type fold

26

0.0582

1.44

1.000

1.000

0.9843

Tyrosine-protein kinase, active site

10

0.0586

2.02

1.000

1.000

0.9843

EF-hand domain

18

0.0589

1.60

1.000

1.000

0.9843

Zinc finger, Btk motif

3

0.0598

7.26

1.000

1.000

0.9843

Epithelial sodium channel

3

0.0598

7.26

1.000

1.000

0.9843

RPEL repeat

3

0.0598

7.26

1.000

1.000

0.9843

Immunoglobulin subtype

23

0.0646

1.47

1.000

1.000

0.9843

Spectrin/alpha-actinin

5

0.0715

3.14

1.000

1.000

0.9843

Calponin homology domain
Immunoglobulin/major histocompatibility complex, conserved
site

8

0.0764

2.15

1.000

1.000

0.9843

6

0.0772

2.61

1.000

1.000

0.9843

Rho GTPase activation protein

9

0.0781

2.01

1.000

1.000

0.9843

C-type lectin-like

9

0.0829

1.98

1.000

1.000

0.9843

Src homology-3 domain

16

0.0864

1.57

1.000

1.000

0.9843

Leucine-rich repeat-containing N-terminal

6

0.0915

2.48

1.000

1.000

0.9843

EGF-like, laminin

5

0.0974

2.82

1.000

1.000

0.9843

Spectrin repeat

4

0.0979

3.57

1.000

1.000

0.9843
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Figure 9. Venn Diagram of GO terms, Interpro terms, genes and pathways organized by
putative phenotypes involved in anthrax resistance
Venn Diagram shows some of the top 20 GO terms (bold), statistically significant Interpro terms
(underlined), the most unique and statistically significant KEGG pathways (italicized), and a few
of the top genes (all capital letters). Terms were selected to reduce the amount of redundancy
(e.g., GO term ‘actin cytoskeleton organization’ is similar to KEGG ‘Regulation of actin
cytoskeleton’).

45

Discussion
Through this case-control GWAS, we identified genes associated with survival outcome
in plains zebra exposed to the Bacillus anthracis pathogen in Etosha National Park (ENP),
Namibia, where anthrax is endemic and outbreaks occur annually. First, our study confirms the
roles of genes and gene pathways salient to anthrax pathogenesis or resistance according to
medical and veterinary studies. Our study also elucidates new genes that are not highly
discussed in the anthrax literature. Notably, we present a novel approach for weighting gene
pathways identified through a GWAS and demonstrate how this approach can be used to
evaluate the relative importance of particular functional pathways in the phenotype of interest,
in this case anthrax resistance.
Our biological function analyses demonstrate that the candidate gene set is composed
of diverse biological functions. Many genes are closely associated with integral host pathways,
such MAPK and PKA signaling, that are disrupted in many cell types by the anthrax toxin lethal
factor (LF) and edema factor (EF), respectively (Moayeri et al. 2015). In addition, we also
identify genes with more specific roles that contribute exclusively towards immune, cardiac,
renal, or nervous system functioning. Thus, surviving anthrax exposures in ENP seems to stem
from multiple phenotypes beyond the capacity of an individual’s immune system. In Moayeri et
al. 2015, anthrax infections are described in two phases: early and systemic, where the host
must first prevent anthrax bacteria from widespread dissemination and then the pathogen goes
on to affect organs, such as the heart and brain. Here, we discuss and reflect on some of the
well-known anthrax-associated genes (n = 26), the top candidate genes (n = 73), and the entire
candidate gene set (n = 1,104) by acknowledging the significant KEGG pathways, GO terms, and
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protein domains these genes are involved in. These data provide valuable insight into the
multiple pathways and processes that may influence resistance to anthrax in a natural wildlife
system during the early and systemic phases of infection.
Genes and gene pathways previously associated with anthrax pathogenesis
Our GWAS results identified several genes that have previously been associated with
anthrax pathogenesis, particularly those involved in pathways relevant to the anthrax toxin
entry into host cells. Perhaps the most significant are the host receptor genes, ANTXR1 and
ANTXR2, which are universally expressed on most cell types and leveraged by the anthrax
protective antigen (PA) to initiate clathrin-dependent endocytosis of anthrax’s virulence factors,
EF and LF (Abrami et al., 2003). In our study, we found a significant variant in an intron of
ANTXR2, but no variant associated with ANTXR1. This supports previous findings demonstrating
that ANTXR1 is less important for toxin entry since ANTXR2 knock outs are completely resistant
(Liu et al., 2009), and thus, ANTXR2 is the major receptor for anthrax toxin (Scobie et al., 2003).
Although significant, this variant was not retained in our top candidate genes despite previous
work in humans demonstrating variable expression contributes enormously to toxin uptake
phenotypes (Martchenko et al., 2012).
Phenotypes related to an individual’s ability to endocytose anthrax toxins likely play a
contributory role in overall resistance to anthrax death. Our GWAS also identified genes
involved or related to the first cellular steps in anthrax toxin-mediated death. Prior to
endocytosis, the furin protein cleaves PA into PA63 and PA20 so that PA63 oligomers can form
a complex, which is then endocytosed by clathirin-coated vesicles along with LF and EF (Klimpel
et al., 1992). Experimental studies indicate that this is a crucial step in anthrax pathogenesis, as
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furin inhibitors significantly reduced anthrax lethality (Opal et al., 2005; Remacle et al., 2010).
Although we did not find a correlation between the FURIN gene and anthrax survival in plains
zebra, our top candidate gene set included ATP2C1, which has a strong link to furin protein
expression (Hoffman et al. 2017). ATP2C1 encodes the calcium-transporting ATPase type 2C
member 1 protein, SPCA1, which is involved with catalyzing ATP hydrolysis to transport calcium
ions into the Golgi apparatus for storage and later use in several cellular processes. Hoffman et
al. 2017 showed that furin production in the Golgi apparatus is destabilized when SPAC1 is
reduced because CA2+ levels also decrease. In addition, we found ‘regulation of cytosolic
calcium ion concentration’ to be one of the top GO terms for the entire gene set and ‘calcium
signaling’ to be a significant KEGG pathway. From these results, we speculate that variable
calcium phenotypes could have varying effects on anthrax resistance via modulating furin and,
subsequently, toxin cleavage rates. Our GWAS also detected the heavily studied, anthrax-linked
LPR6 gene. LPR6 is a canonical Wnt signaling pathway co-receptor gene and there are mixed
findings in the literature regarding its significance in anthrax toxin absorption during the
endocytosis process (Qian et al., 2014; Ryan & Young, 2008; Wei et al., 2006).
Extracellular membrane, cell membrane, and cytoskeleton composition phenotypes
could also play a role in resisting anthrax mortality because of their speculative pertinence in
toxin endocytosis. Extracellular matrix and cell membrane proteins, the primary proteoglycans,
provide physical structures to withstand compressional force, but they also have large
implications for cancer (Iozzo & Sanderson, 2011) and infectious disease pathogenesis (Bartlett
& Park, 2010). A significant KEGG pathway was identified through our GWAS was
‘Proteoglycans in Cancer’, which directed us to two types of proteoglycans, chrondoitin and
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heparin sulfates, which may be associated with survival in plains zebra. In mouse macrophages,
chrondoitin sulfate C decreased PA binding to toxin receptors, however a mechanism was not
reported and no relationship was found between heparin sulfate and anthrax toxicity (Ahn et
al., 2012). In addition, we found three genes (NDST4, HS6ST3, and HS3ST3B1) involved in the
biosynthesis of the proteoglycans, heparin and chrondoitin, one of which (HS3ST3B1) was
amongst the top candidate genes. The role of proteoglycans in anthrax toxin absorption might
be species-specific and warrants further investigation. In addition, it is known that the
cytoskeleton plays an important role in mediating the absorption of anthrax toxins (Abrami et
al., 2010), and we found ‘Regulation of actin cytoskeleton’ was statistically significant in our
GWAS, but only before correction. Lastly, we uncovered the EXOC6B in our top candidate gene
set. The EXOC6B gene encodes the Sec15 protein which is important for endocytic recycling and
is jointly disrupted by LF and EF anthrax toxins (Guichard et al. 2010).
A host’s ability to compensate the effects of LF and EF through relevant signaling
pathways after they enter cells is another plausible route of resistance. Anthrax LF is well
known for cleaving MAP kinase kinases (MAP2Ks), the upstream regulators of MAPK signaling
pathways; ERK1, ERK2, p38, JNK, and ERK5 are each responsible for regulating different
biological processes depending on the cell type and are important in cell cycle regulation
(Zhang & Liu, 2002). Our GWAS detected two MAP2K genes, MAP2K3 and MAP2K4, which
encode proteins that are upstream of p38 and JNK, respectively, and 20 other proteins involved
in MAPK signaling. Recently, additional substrate genes PIK3R1 and PIK3R2 encode regulatory
subunits of PI3K, which were confirmed to be cleaved by LF as well (Mendenhall et al., 2020). In
our GWAS, the gene encoding the protein downstream of PI3K, AKT, was associated with
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surviving anthrax infections. Thus, we suspect the MAP2K and PI3K proteins may be cleaved by
LF in plains zebra as well. The second anthrax toxin, EF, is a calcium and calmodulin dependent
adenyl cyclase, which means it rapidly generates cAMP in the presence of calcium and CaM
proteins upon entering the cytosol (Tang & Guo, 2009). We identified two genes in plains zebra
associated with survival, ADCY2 and CAMK2D, that are known to similarly regulate cytosol Ca2+
levels. Of all the genes discussed in this section, however, only CAMK2D was a top candidate
gene.
Innate and Adaptive Immune Response
Innate Immunity
The first layer of host defense against invading pathogens is the innate immune
response, which includes the physical and chemical barriers that prevent initial entry of
pathogens into host cells. In ENP, the cogent hypothesis for the primary route of infection for
plains zebra is through ingestion. This is supported by the following lines of evidence: (1) soil
ingestion is higher in the wet season, coinciding with anthrax outbreaks in grazing herbivores in
the park (Turner et al., 2013), (2) carcass sites have higher grazing frequencies then non-carcass
sites (Turner et al., 2014), and (3) zebra mortality locations in ENP are positively associated with
vegetation greenness (Huang et al., in review). Given the likely important role of foraging in B.
anthracis exposure and transmission, zebra would be expected to acquire B. anthracis either
through the proximal digestive or intestinal epithelium. Related to this hypothesized
transmission mechanisms, one of our top gene hits was a splice variant of the desmoglein 1,
DSG1, protein coding gene, which is highly expressed in keratinocytes in the skin, as well as the
tongue and esophagus along the proximal digestive tract of humans (Human Protein Atlas). In
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humans, mutations of this gene are associated with the autoimmune disorder, pemphigus,
where autoimmune antibodies attack DSG1 and DSG3 proteins and cause blistering of
mucocutaneous membranes, such as the linings of the inner mouth (Kasperkiewicz et al., 2017).
Our finding that DSG1 alleles differed between zebra survivors versus non-survivors hints at the
hypothesis that anthrax infections in plains zebra may largely stem from crossing the oral rather
than intestinal epithelial barrier. However, the exact mechanism by which anthrax penetrates
its host during ingestion is not well known (Goossens & Tournier, 2015). We suggest that DSG1
is a top candidate gene for future study, especially since gastrointestinal anthrax is also the
main form of the disease affecting livestock (Beyer & Turnbull, 2009).
Host white blood cells involved in innate immunity, such as macrophages, dendritic
cells, natural killer cells, and neutrophils are critical in the immediate defense against
pathogens, and B. anthracis must target these cells to disseminate and establish successful
infections (Liu et al., 2010). Despite how critically important it is for anthrax to defeat the innate
immune response, we found only two of the top GO terms (macrophage differentiation, and
positive regulation of phagocytosis), one of the top KEGG pathways (phagocytosis), and only
one of the top genes (EYA4) had a clear link to the innate immune system in ENP’s plains zebra
population. The top candidate gene, EYA4, stimulates cytokine production in response to
undigested DNA, particularly viral DNA, from intracellular pathogens of apoptotic cells (Okabe
et al., 2009). Anthrax, however, only has a transient intracellular phase when it is still in its
spore form (Tonello & Zornetta, 2012), so whether EYA4 can be activated as a result of anthrax
infection is unclear. Nonetheless, although we found minimal evidence to support a genetic
basis for innate immunity in anthrax resistance, these data do not preclude the importance of
51

innate immune system phenotypes in resistance, because the environment, coinfections, or
other physiological characteristics may shape heterogeneity in innate immune responses to
anthrax infections.
Adaptive Immunity
T-cell receptors bind to the pathogen-specific MHC antigen presenters on the surface of
macrophages and other host cells to initiate a further cascade of immune responses, including
the proliferation and release of cytokines that attract additional immune cells. Disrupting this
process, B. anthracis depletes the ability of T-cells to initiate an immune cascade by suppressing
cytokine release (Comer et al., 2005). Here, we found variants linked to T-cell induced immunity
that are associated with resistance to anthrax. First, we found that the T-cell signaling pathway,
as well as the GO-term, MHC antigen presentation, were statistically significant (but only before
correction) and that genetic variants across MHC type I (EQMHCB2) and type II (DRA, DRB, and
DQA) presenter molecules contribute towards survivorship. Indeed, one of these genes, MHC
type I gene, EQMHCB2, was amongst the top outliers, in addition to a T-cell receptor, TRAV,
which binds the MHC molecules to instigate cytokine release (Davis et al., 1998). In addition, we
found other T-cell surface proteins, more specifically a T-cell co-receptor CD28 and receptor
CD69, but they were not in the top outlier gene set. Lastly, we found two of the top candidate
genes, CLPTM1 and SIGLEC15, have speculative roles in T-cell development (Takeuchi et al.,
1997) and T-cell initiation (Angata, 2020), respectively. Siglec proteins, like Siglec-15, however,
are known for interacting with sialic acid-expressing pathogens, which B. anthracis is not
confirmed to be. Recently, however, an association between Mycobacterium tuberculosis
infections, another non-sialic bacterium, and a SIGLEC15 polymorphism was found in humans;
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this finding suggests non-sialic acid expressing pathogens, such as B. anthracis, could interact
with this protein as well (Bhattacharyya et al., 2019). Precisely how these genotypes affect
individuals’ immune phenotype, and likewise how the phenotype contributes to anthrax
pathogenesis is equivocal without further genotype-phenotype study. Nonetheless, we
postulate that immune phenotypes, especially involving T-cells, may influence individual
heterogeneity in host adaptive immune responses to “natural vaccination” through exposures
to sublethal spore dosages, which result in the production of pathogen-specific antibodies for
future infections. In humans, for example, MHC genotypes partially describe why some
individuals have higher antibody counts after receiving the anthrax vaccine (Pajewski et al.,
2012), and increases survival probability in transgenic mice (Ascough et al., 2019).
Natural Killer T (NKT) cells are a subset of T-cell lymphocytes that are important
activators of B-cells, the second pathogen-specific pathway of adaptive, or humoral, immunity
during anthrax infections; thus, NKT and B cells are also likely contributors of individual
heterogeneity in antibody response. It has previously been shown that an interaction between
the NKT cell receptor, KLRK1, and B-cell receptor, CD1D, promotes a greater and more
sustained antibody response in vivo (Devera et al., 2010). In our results, we found a significant,
downstream variant of KLRK1, which was also physically close to variants near other NKT cell
surface receptors (KLRD1 and KLRF1). At this stage, we have not been able to determine
whether variants may be in linkage disequilibrium, and it is possible that the appearance KLRK1
is just an artefact of another, nearby NKT receptor variant. We also found a critical mediator of
B-cell receptor signaling, BLNK (Koretzky et al., 2006), was one of the top genes associated with
anthrax survival outcome, which has not been described in the anthrax literature before. As a
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top candidate gene, BLNK further implicates the importance of the genetic basis and
heterogeneity in plains zebra adaptive immune response for surviving anthrax outbreaks in
ENP.
Systemic Anthrax
Nervous System
Interestingly, we found many statistically significant biological functions related to the
nervous system, specifically those involving axon guidance and generation. Recent studies have
demonstrated that axon guidance molecules have pertinent roles in calling an inflammatory
response to peripheral organs and tissues of the central nervous system that are affected
during the systemic phase of anthrax (Lee et al., 2019). Of the 13 axon guidance molecules we
identified, 5 have confirmed roles in neuroinflammation (DCC, EPHB1, EPHA4, ROBO1, SEMA4D;
Lee et al., 2019), but we suspect more of these have unknown roles in neuroinflammation as
the roles of axon guidance molecules in stimulating immune responses requires further study.
While neurological symptoms and meningitis are common in systemic anthrax (Lanska,
2002), little is known about how anthrax crosses the blood-brain barrier (BBB) or affects the
nervous system (Xie et al., 2011). Anthrax can penetrate the BBB via two mechanisms involving
the anthrax proteins, BsIA and LT, which disrupt tight junction protein 1, an identified gene in
this study, thereby increasing BBB permeability (Ebrahimi et al., 2009, 2011). Interestingly, in
our top candidate gene set, we also identified an axon guidance netrin-1 receptor, UNC5C,
which is almost exclusively expressed in the brain and detected at low levels in the BBB
endothelium (Podjaski et al., 2015). Podjaski et al., 2015, found that when netrin-1 expression is
reduced, the BBB permeability increases though modulation of junction proteins. Interestingly,
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netrin-1 was considered one of a few plausible candidate genes, from a chromosomal segment,
associated with increasing survivorship of mice to anthrax infections (Terra et al., 2011). We
also identified two additional netrin-1 receptors, DCC and UNC5CL, that were associated with
anthrax survivorship in zebras. Given our results, the role of netrin-1 signaling in anthrax
resistance is in an intriguing avenue for medical and veterinary research to better understand
resistance to anthrax at the systemic stage.
Symptoms of the systemic phase of anthrax infection, like hypotension, may be a
consequence of toxins interfering with the autonomic nervous system (Garcia et al., 2012). We
found ‘Cholinergic Synapse’ to be a significant KEGG Pathway because of two cholinergic
receptors and three potassium channels (one of which, KCNQ3, was in the top 50 genes) that
are expressed at cholinergic synapses. Even though high involvement of other proteins
removed this pathway from the network analysis, the ‘Neuroactive Ligand Receptor’ KEGG
Pathway remained, which encompassed the cholinergic receptors. One of these, CHRM3, is the
sole muscarinic cholinergic synapse expressed on pancreatic and gastrointestinal cells and
affects insulin and gastric acid secretion (Aihara et al., 2005; Guo et al., 2006), suggesting that a
CHRM3 genotype may either increase or decrease resistance to anthrax at either the early
stage of gastrointestinal infection or via an insulin mechanism at the immune or systemic stage
of infection. Both of these KEGG Pathways were also significant before correction, but
‘Cholinergic synapse’ was removed during the network analysis, likely because this pathway
involves many genes overlapping with the MAPK and calcium signaling pathways.
Ionotropic glutamate receptors modulate synaptic plasticity and are responsible for the
initial influx of ions (calcium, potassium, or sodium) that create the electron potential for
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synaptic transmission when they are stimulated by glutamate neurotransmitters (Traynelis et
al., 2010). Our GWAS detected several variants associated with ionotropic glutamate receptors,
indicated by the statistically significant Interpro domains: ‘NMDA receptor’, ‘Glutamate
receptor’, and ‘Ionotropic glutamate receptor’. In addition, one of the top genes, GRIK1, a
kainite glutamate ionotropic receptor, was among the top genes in all three tests. To our
knowledge, the relationship between glutamate signaling and responses to anthrax infections
has not been investigated; therefore, it is difficult to deduce why these genes are associated
with zebras surviving anthrax outbreaks. Previous studies in rhesus macaques (Macaca
mulatta) and chimpanzees (Pan troglodytes) demonstrated that purified anthrax toxins, LF and
EF, almost immediately alter electroencephalogram (EEG) tests once they cross the BBB, and
quickly thereafter induce coma and dysregulate cardiac output (Klein et al., 1968; Vick et al.,
1968). Since increasing glutamate signaling causes neurotoxicity and leads to cell death (Ribeiro
et al., 2010), it is possible that the abhorrent EEGs observed were a consequence of LF and EF
interfering with glutamate signaling. However, glutamate receptors have also been found on
peripheral organs including the heart, intestine, liver, lungs, and more (Gill & Pulido, 2001;
Nedergaard et al., 2002). Given the ionotropic glutamate receptors can regulate cytosolic Ca2+
concentrations (Traynelis et al., 2010), a plausible hypothesis is that different expression
profiles of these receptors, driven by genomic variation across the zebra population, introduces
variable levels of tolerance to calcium-dependent EF.
Alternatively, given the importance of ionotropic receptors in modulating synaptic
plasticity, learning, memory, and long-term potentiation (Willard & Koochekpour, 2013), there
could be behavioral phenotypes that reduce anthrax exposure rooted from differential
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expression profiles across individuals. In rats, glutamate signaling increases during sign-tracking
for food stimuli (Batten et al., 2018). Sign-tracking is a behavior that is driven by a learned
association between some stimulus and a positive outcome. Previous research in ENP shows
that herbivores are attracted to the more nutrient-rich grasses subsisting on decayed anthrax
carcasses and contagious spores (Ganz et al., 2014; Turner et al., 2014). This suggests there is,
at the very least, a learned association in herbivores between greener grass and nutrient
content. Furthermore, our top candidate gene, JPH3, is annotated with the GO terms
‘exploration behavior, learning, and memory’ further emphasizing a potential role for
behavioral phenotypes in survival outcome. In our case and control individuals, we don’t have
precise estimates of the variation in spore exposure frequency, so whether behavior
characteristics increase an individual’s probability of surviving annual outbreaks is unknown.
However, zebra movement data demonstrates that a portion of the population migrates east
during the dry season and that intraspecific competition when migrators returns drives
heterogeneity in habitat use between the migrators and non-migrators (Zidon et al., 2017).
Whether, glutamate receptors drive physiological or behavioral phenotypes in decision-making
or migration strategies will remain a puzzle until further genotype-phenotype studies are
performed involving these receptors.
Vascular and Cardiovascular System
Vascular endothelial cells are a primary target of anthrax toxins; they express the
greatest amount of anthrax toxins of all other cell types (Bell et al., 2001). The two toxins
conjointly cause vasculitis, vascular leakage, and hemorrhaging through endothelial cell
targeting and as infection spreads hypovolemia, pulmonary and peripheral edemas, and
57

hypotension are contributory to host death (Golden et al., 2009). We found evidence in plains
zebra that resistance to anthrax stems from mitigating the effects of toxins on vascular
endothelial functioning. First, at vascular endothelial cells, LT increases VCAM1 expression
because it induces NF-kB and IRF-1 (Warfel & D’Agnillo, 2008), which then decrease host
immunity as monocytes adhere to these overly expressed proteins on the endothelial lining
(Steele et al., 2005). Our GWAS identified a differentiated intron variant at VCAM1 between
zebra cases and controls, suggesting the effect of LT on VCAM1 expression could be
heterogeneous in the population. Second, LT and ET modulate endothelial cell chemotaxis
(Hong et al., 2007), disrupt endocytic recycling (Guichard et al., 2010), and alter expression of
stress actin and surface adherens junction molecules in endothelial cells at the systemic phase
(Warfel et al., 2005), all of which increase the permeability and decrease the integrity of the
vascular walls. The two KEGG pathways ‘Adherens junction’ and ‘Regulation of actin
cytoskeleton,’ which included two top genes PDGFD and FGF12, were statistically significant in
our GWAS (but only before correction) and kept after the network analysis, confirming the
importance of these pathways and resistance by combatting against the effects of toxins at the
systemic phase. In addition, the top candidate gene, HACE1 is involved in the ubiquitination of
RAC1, which is an important mediator of actin and target of EF (Mettouchi & Lemichez, 2012).
In many species, cardiovascular dysregulations are reported in the hours preceding host
death, but there is no consensus on how anthrax affects the cardiovascular system or causes
death because it varies across infection modes and species (Golden et al., 2009). In plains zebra,
the involvement of the cardiac system and cause of death is even lesser known. We did,
however, find that the KEGG pathway ‘Arrhythmogenic right ventricular cardiomyopathy’ was
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statistically significant (but only before correction) and highly unique according to the network
analysis, hinting some importance of the cardiovascular system. Arrhythmogenic right
ventricular cardiomyopathy is a form of heart disease where heart tissue is gradually
replenished with fibrous fatty tissue (McKenna et al., 1994). We suspect this pathway probably
appeared due to the strong connection between arrhythmogenic right ventricular
cardiomyopathy and calcium signaling (Moccia et al., 2019), as the genes we identified in this
pathway are either intracellular calcium regulators (CACNG1, CACNG7, CACNA1C, RYR2) or are
affected by calcium levels (DSC2, LMNA) (Morales Rodriguez et al., 2020; Nollet et al., 2000). It
is possible that genes affected by calcium levels are not involved in anthrax pathogenesis, but
rather genetically linked or inherited with other genes that are. In which case, cardiac
phenotypes caused by mutations in DSC2 and LMNA may be correlated, but not associated
with, anthrax survival. In addition, we identified CAMK2D in the top gene outliers, which is
differentially expressed in cardiomyocytes and widely described in literature for its role in
cardiac output (Little et al., 2007), as evidenced by its direct GO terms: ‘cardiac muscle
contraction’ and ‘regulation of relaxation of cardiac muscle’ . Specifically, this protein jointly
regulates the influx of ions through calcium channels of the membrane and sarcoplasmic
reticulum in myocytes with PKA, the target EF protein. Golden et al., 2009, suggest that in the
heart there is excessive phosphorylation by these two proteins during anthrax infections as a
result of EF, and that a subsequent increase in cytosolic calcium and dephosphorylation of
myosin light chains (such as MYLK4, a gene found in our GWAS) causes vascular dilation and
hypotension. Here, we speculate there is a plausible role for these genes in withstanding
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systemic anthrax via the cardiac system, but more research is needed to ossify why these genes
are associated with surviving anthrax outbreaks.
Limitations
It is important to address the limitations of our study design and interpretation, since
wildlife GWAS have lesser access to samples, reference genomes, annotations, and controlled
environments than human studies. One of the largest limitations of genomics research in
wildlife is having limited sample sizes which reduce a study’s statistical power, so it remains
difficult to describe the relative effect sizes of genes, parse apart genes correlated because of
linkage disequilibrium (LD) and avoid false positives. In this study, we did not filter for LD or
consider multiple testing corrections to mitigate the number of false positives, which will be a
necessary downstream step. However, to address false positives at this stage, we compared the
top gene set functions, or genes we suspect to be least likely false positives, with the entire
gene sets.
We found very few GO terms, KEGG pathways, and Interpro terms that were statistically
significant after correction for multiple testing, so we took a less conservative approach to
analyzing and discussing these results. Thus, we could have falsely concluded the significance of
specific pathways and terms. Typically, GWAS studies employ larger sample sizes to gain the
statistical power to adequately correct for multiple tests; we did not account for multiple
testing in selecting out significant variants. It is important to note that with an increased sample
size, we might expect the ranking and effect sizes of our top genes to change. In addition to the
limitations of false positives due to small sample sizes, we may also have falsely described the
reason for top genes being candidate genes in anthrax survivorship since genes can be
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pleiotropic or under-described in the scientific community. Here, we speculate plausible
explanations for why genes could have appeared within our top gene set, but further
investigation is needed to link these genotypes to phenotypes that confer greater or lesser
chance of survival. Nevertheless, these results glean genes with plausible roles in pathogenesis
and should be future researched for their effects on host susceptibility to anthrax.
Last, we acknowledge the caveats of our control sample selection where we selected
individuals that we knew to be exposed to anthrax spores at least once based upon serology. A
confirmation of exposure through anti-PA titres does not account for variation in B. anthracis
exposure dose. Here we assume an individual survived infection because it has either higher or
lower susceptibility, but because we were unable to control for exposure frequency or total
dose, our design is not a perfect test for resistance to anthrax infections. On the other hand,
this could have resulted in the identification of genes influencing variation in exposure dose,
rather than resistance, thereby affecting survival outcome. Interestingly, we did find behavioral
phenotypes rooted in genomic variants that may affect the probability of an individual surviving
these recurrent anthrax outbreaks.
Conclusions and Future Directions
The putative candidate genes identified in this study belonged to a diversity of
pathways, functions, and organs. We found that many of the pathways and functions seemed
more related to the systemic phase of anthrax infection, rather than to the immune phase
exclusively (Figure 9). These results also introduce the question of how behavioral phenotypes
affect the survival probability of individuals surviving outbreaks. A similar result was found in
Hubert et al., 2018, where genes related to behavior and immunity were identified in
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Tasmanian devils (Sarcophilus harrisii) that survived facial tumor disease. Our results further
highlight the importance of using NGS technologies to identify genes involved with disease
resistance beyond those with well-known immune response functions.
While we confirmed previously reported genes involved in anthrax pathogenesis, such
as the well-known ANTXR2 receptor, we also identified genes not previously described in
anthrax literature that will require genotype-phenotype investigations to accurately describe
their contribution to anthrax disease resistance. For example, it is unknown why our top gene,
DSG1, is strongly associated with survival, but we can speculate its role in gastrointestinal
anthrax infections. How this gene contributes to surviving anthrax outbreaks, though, should be
studied for its potential in developing strategies for mitigating anthrax outbreaks in affected
livestock and wildlife.
Last, we expect these results to contribute further to our understanding of anthrax
dynamics in endemic systems like ENP. Further work will identify if these genes are under
strong natural selection by anthrax, if certain variants are correlated with specific strains, or if
these variants interact with environmental variables as well as other pathogens. Further
examination of the relationships between genotypes, phenotypes (e.g. feeding behaviors,
antibody responses, baseline metabolisms, etc.), and other interacting variables may help us
better understand why zebras are the primary host of ENP and explain the wide variation in
anthrax outbreak dynamics observed across study systems globally.
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APPENDIX 1
Table A.1.1. Plains zebra sample metadata
All plains zebra samples used in this study are listed. Associated data collected from plain zebra
are shown: sex (M = male, F = Female), age (J = juvenile, SA = subadult, AD = adult, AO, old
adult), status, (N = non-survivor/case, S = survivor/control), date of first capture or death
(Year/Month of either the first capture for controls or the month of death by anthrax for cases),
subsequent captures (Year/Month of captures if individual was handled multiple times), and
serology (antibody titer at each capture in chronological order).

Individual

Sex

Age

Status

First
Capture or
Death

EB080324-OS
EB080415-OS-01
EB080405-PK
EB080305-OS
EB080407-MK
EB081106-GS
0946
0962
0964
0965
0969
0993
0994
09-144
09-153
09-155
10-017
10-028

F
M
M
M
M
M
M
M
M
F
F
M
M
M
F
F
F
M

AD
SA
AD
AD
AD
AD
AD
AD
NA
NA
NA
AD
AD
AO
SA
J
AD
AD

N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N

2008/03
2008/04
2008/04
2008/04
2008/04
2008/04
2009/03
2009/04
2009/04
2009/04
2009/04
2009/04
2009/04
2009/10
2009/11
2009/11
2010/02
2010/02

10-033
10-040

M
F

AD
J

N
N

2010/02
2010/02

10-044
10-064

F
F

AD
AD

N
N

2010/02
2010/02

10-073
10-083

F
M

AD
AD

N
N

2010/03
2010/03

10-124
10-190
10-191

F
M
M

AD
AD
AD

N
N
N

2010/04
2010/06
2010/06
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Subsequent Captures

Serology

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

Table A.1.1. Continued
M2
M4
M5
F24

M
M
M
F

SA
AD
AD
SA

S
S
S
S

2008/04
2008/04
2008/04
2008/04

F25

F

AD

S

2008/04

F26

F

AD

S

2008/04

F28

F

AD

S

2008/04

F29

F

AD

S

2008/04

F30

F

SA

S

2008/04

64
16

NA
NA

1024
8, 256

NA
2008/10
2009/04, 2010,
08

32, 512, 128
8

F32

F

AD

S

2008/04

F33
F34

F
F

AO
AD

S
S

2008/04
2008/04

F35

F

AD

S

2008/04

F36

F

AD

S

2008/04

F37

F

AD

S

2008/04

F38

F

AD

S

2008/04

EQ63

F

AD

S

2008/10

EQ64
EQ66

F
F

SA
AD

S
S

2008/10
2008/10

EQ68

F

AD

S

2008/10

128, 128, 32

2008/10,
08/2010
2008/10
2008/10,
2009/04,
2009/11,
2010/08
2009/04,
2009/11,
2010/08
2009/04
NA
2008/10,
2009/04
2008/10,
2009/04,
2009/11
2008/10,
2009/04,
2010/08
2008/10,
2009/11,
2010/08
2009/04,
2009/11,
2010/08
NA
2009/04
2009/04,
2010/08

EQ70
EQ71

F
M

AD
AD

S
S

2008/10
2008/10

512
NEG, 128

NA
2009/04

EQ72
EQ74

F
F

AD
AD

S
S

2008/10
2008/10

EQ75
EQ76

F
M

AD
AD

S
S

2008/10
2008/10

128, 128
128, 256
64, 128
8

2009/04
2009/04
2009/04
NA

256, NEG, 256
NEG, 32

NEG, 64, 128, 256, 64
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NEG, 64, 64, 32
64, 64
64
NEG, 16, 16
64, 128, NEG, 128
128, 128, 128, 128
64, 128, 512, 256
64, 32, NEG, 128
16
256, 128

EQ77

M

AD

S

2008/10

EQ83

F

AD

S

2008/10

EQ119

F

AD

S

2009/05

EQ120

F

AD

S

EQ121

F

AD

S

2009/05

8, NEG, 128
64
256

NA
2009/11,
2010/08
NA
NA

2009/05

256

NA

NA: Data not applicable or available
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Table A.1.2. Sequencing results for each sample
All samples are listed with their number of clean reads, the percent of the total reads that are
clean, the coverage, the percent variant callings missing, and inbreeding coefficient. Two
samples indicated with * were removed after BQSR because they had exceptionally high
heterozygosity/low inbreeding coefficients.
Sample

Clean Reads

% Reads >
Q20

Coverage

%
Missingness

Inbreeding
Coefficient

EB080324-OS
EB080415-OS-01

37,331,836,200
37,470,883,000

0.975
0.981

14.43
14.49

0.00265
0.00270

0.005
0.052

EB080405-PK
EB080305-OS

37,028,686,600
37,077,343,200

0.975
0.98

14.32
14.33

0.00341
0.00307

0.047
0.04

EB080407-MK
EB081106-GS
0946
0962
0964
0965
0969
0993
0994
09-144
09-153
09-155
10-017
10-028
10-033
10-040
10-044
10-064
10-073
10-083
10-124
10-190
10-191
M2
M4
M5
F24
F25

36,955,073,200
37,787,365,800
37,165,260,795
36,683,387,600
37,208,818,701
31,297,839,042
31,290,292,698
32,482,096,872
37,512,225,800
33,507,168,804
36,712,804,971
37,107,557,715
33,965,415,000
33,201,282,800
36,368,709,800
36,933,319,200
37,217,100,600
36,926,070,200
36,917,386,400
31,552,516,000
37,111,207,200
37,266,245,200
37,383,981,400
37,242,389,800
36,921,752,400
36,686,692,000
37,077,018,400
36,592,720,800

0.977
0.964
0.98
0.976
0.982
0.98
0.982
0.982
0.976
0.981
0.981
0.983
0.976
0.976
0.975
0.976
0.977
0.979
0.977
0.975
0.978
0.978
0.98
0.971
0.974
0.972
0.973
0.971

14.29
14.61
14.37
14.18
14.38
12.1
12.1
12.56
14.5
12.95
14.19
14.35
13.13
12.84
14.06
14.28
14.39
14.28
14.27
12.2
14.35
14.41
14.45
14.4
14.27
14.18
14.33
14.15

0.00267
0.00336
0.00307
0.00295
0.00271
0.00318
0.00328
0.00345
0.00268
0.00333
0.00243
0.00305
0.00328
0.00378
0.00293
0.00302
0.00310
0.00301
0.00298
0.00364
0.00322
0.00302
0.00292
0.00358
0.00323
0.00367
0.00415
0.00310

0.036
0.048
0.086
0.04
0.05
0.019
0.069
0.026
0.029
0.056
0.021
0.009
0.025
0.056
0.038
-0.005
0.005
0.017
0.009
0.019
0.011
0.037
0.011
0.06
0.048
0.06
0.018
0.015
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Table A.1.2. Continued
F26
F28
F29
F30
F32
F33
F34
F35
F36*
F37
F38
EQ63
EQ64
EQ66
EQ68
EQ70
EQ71
EQ72*
EQ74
EQ75
EQ76
EQ77
EQ83
EQ119
EQ120

36,661,716,600
37,331,675,600
36,780,387,400
36,838,026,200
31,898,647,400
31,286,666,600
36,805,217,000
36,977,446,200
37,048,893,800
36,648,302,600
34,525,449,200
37,028,420,400
36,891,921,000
37,277,421,600
33,814,004,000
36,829,644,200
36,868,339,800
36,710,630,800
35,120,887,400
36,690,779,000
37,183,314,200
37,408,115,000
37,183,991,400
36,943,658,400
36,832,589,400

0.967
0.973
0.966
0.967
0.967
0.964
0.966
0.964
0.97
0.971
0.971
0.974
0.978
0.978
0.978
0.978
0.97
0.973
0.973
0.974
0.975
0.975
0.968
0.969
0.975

14.17
14.43
14.22
14.24
12.33
12.1
14.23
14.3
14.32
14.17
13.35
14.32
14.26
14.41
13.07
14.24
14.25
14.19
13.58
14.18
14.38
14.46
14.38
14.28
14.24

0.00429
0.00370
0.00430
0.00409
0.00470
0.00484
0.00387
0.00367

0.00345
0.00354
0.00314
0.00317
0.00338
0.00379
0.00334

0.045
0.005
0.029
0.017
0.05
0.047
0.019
0.034
-0.184
0.009
0.015
0.011
0.014
0.004
0.033
0.026
0.044
-0.625
0.084
0.026
0.058
0.052
0.02
0.023
-0.005

EQ121

37,342,314,400

0.969

14.44

0.00375

0.011
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0.00332
0.00329
0.00304
0.00343
0.00265
0.00326
0.00339
0.00382

APPENDIX 2
zebra_genome_fasta="/home/cdickson/Anthrax/Zebra_Genome/Equus_qu
agga_HiC.fasta" # make sure it is indexed
horse_gff3="/home/cdickson/Anthrax/Zebra_Genome/GCF_002863925.1_
EquCab3.0_genomic.gff "
zebra_gff3="/home/cdickson/Anthrax/Zebra_Genome/Equus_quagga_gen
es_justgenes.gff3"
horse_genome_database="/home/cdickson/Anthrax/Zebra_Genome/GCF_0
02863925.1_EquCab3.0_genomic"
snpeff="/home/cdickson/snpEff/snpEff.jar"
biostar251649="/home/cdickson/jvarkit/dist/biostar251649.jar"
bioalcidaejdk="/home/cdickson/jvarkit/dist/bioalcidaejdk.jar"
top_snps_file="TOPSNPS.recode.vcf"
#Make fasta file of top SNPs flanking 50 bp
echo "making fasta file, flanking 50 bp, for top variants"
module load java
java -jar $biostar251649 -R $zebra_genome_fasta $top_snps_file n 50 2>/dev/null |\
java -jar $bioalcidaejdk -F VCF -e 'stream().forEach(V>println(">"+V.getContig()+":"+V.getStart()+"\n"+V.getAttribute(
"SEQ5_50")+"["+V.getAlleles().stream().map(A>A.getDisplayString()).collect(Collectors.joining("/"))+"]"+V.ge
tAttribute("SEQ3_50")));' 2>/dev/null > TOPSNPS.fa
sed -i 's/\[.*\]//g' TOPSNPS.fa # edit fasta files to remove the
position describing the variant, otherwise subsequent steps
won't run
#blastn - blasting the 100 nucleotide sequences to the horse
genome
module load anaconda3
source activate blast
echo "running blastn on topsnps fasta file"
blastn -query TOPSNPS.fa -db $horse_genome_database -out
blastn_horse_results -outfmt 6 -max_target_seqs 1 -max_hsps 3
echo "done running blastn"
rm TOPSNPS.fa
aligned=$(awk '{print $1}' blastn_horse_results | sort | uniq |
wc -l) # count number of positions that aligned
echo "$aligned variants aligned to horse"
#Editted file in R at this step because Chromosome IDs in the
horse fasta file did not match gff3 file, changed the chromosome
IDs in file to match gff3
echo "editting blastn_horse_results in R"
module load R
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Rscript blastn_horse_editting.R
echo "Done editting blastn_horse_results in R"
#retreive SNPS that aligned only once to horse genome
echo "Retrieving variants that aligned to horse just once"
awk '{k=($2"\t"$3"\t"$10"\t"$11)} {a[$2]++;b[$2]=k}END{for(x in
a)if(a[x]==1)print b[x]}' blastn_horse_results | sed 's/"//g' |
tail -n +2 > blastn_horse_results_unique
unique=$(wc -l blastn_horse_results_unique) # count number of
unique alignments
echo "$aligned variants aligned to horse once"
#make bed 50 file
echo "Making bed file"
awk '{if ($3>$2) print $0; else print $1,$2,$4,$3;}'
blastn_horse_results_unique > blastn_horse_50.bed
#prepare horse and zebra gff3 files
grep -v '#' $horse_gff3 | grep -v region | grep -v Genomic| awk
'{print $1"\t"$3"\t"$4"\t"$2"\t"$5"\t"$6}' > Equus_caballus.gff
awk '$4 != "exon"' Equus_caballus.gff |\ # removing these for
when I test 1000,5000, and 10000 bp away, these annotations are
redundant for this
awk '$4 != "CDS"' |\
awk '$4 != "mRNA"' > Equus_caballus_genes_only.gff3
module load bedtools
#here I used bedtools intersect to determine if SNPS lay within
horse genes (0), 1000 bp from horse genes, 5000 bp from horse
genes, or 10000 bp from horse genes
for i in {0,1000,5000,10000}
do
if [ "$i" -lt "2" ]
then
awk '{printf "%s %.f %.f %s\n" ,$2, (($4-$3)/2)+$3, (($4$3)/2)+$3,$1}' blastn_horse_50.bed | sed $'s/ /\t/g' >
blast_horse_0.bed
bedtools intersect -a blast_horse_0.bed -b
Equus_caballus.gff -wa -wb | grep -v mRNA | grep -v region |sort
| uniq | awk -vOFS='\t' '{for(i=1; i<=10; i++) if ($i=="")
$i="NA"; print $0}' > 0_horsegenes.bed
echo "Done making ${i}_horsegenes.bed"
else
awk -v s=${i} '{print $2"\t"$3-s"\t"$4+s"\t"$1}'
blastn_horse_50.bed > blast_horse_${i}.bed
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awk -vOFS='\t' '{for(i=1;i<=NF;i++)if($i<0||$i=="nan")$i=0}1' blast_horse_${i}.bed > tmp${i}.bed
awk '{print $4}' 0_horsegenes.bed | sort | uniq > tmp_${i}
if [ "$i" -gt "1001" ]
then
awk '{print $4}' 1000_horsegenes.bed | sort | uniq >>
tmp_${i}
if [ "$i" -gt "5001" ]
then
awk '{print $4}' 5000_horsegenes.bed | sort | uniq
>> tmp_${i}
fi
fi
comm -1 -3 <(sort tmp_${i}) <(awk '{print $1}'
blastn_horse_results_unique | sort | head -n -1) > tmp2_${i}
cat tmp2_${i} | while read line
do
grep $line tmp${i}.bed
done > tmp2_${i}.bed
bedtools intersect -a tmp2_${i}.bed -b
Equus_caballus_genes_only.gff3 -wa -wb | sort | uniq | awk vOFS='\t' '{for(i=1; i<=10; i++) if ($i=="") $i="NA"; print $0}'
> ${i}_horsegenes.bed
echo "Done making ${i}_horsegenes.bed"
fi
rm blast_horse_${i}.bed
echo "Running SNPEFF -ud $i on $top_snps_file"
java -jar ~/snpEff/snpEff.jar -v Equus_quagga -ud $i
$top_snps_file > TOPSNPS.ann.${i}.vcf 2>/dev/null
echo "Done running SNPEFF -ud $i on $top_snps_file"
awk '{print $4}' ${i}_horsegenes.bed | sort | uniq | while
read line
do
grep $line TOPSNPS.ann.${i}.vcf
done | awk '{print $3"\t"$4"\t"$5"\t"$8}' > tmp3_${i}
join -1 4 -2 1 <(sort -k 4 ${i}_horsegenes.bed) <(sort -k 1
tmp3_${i}) | sed "s/|/ /g" > tmp4_${i}
awk '{if ($14 == "intergenic_region") print $0;}' tmp4_${i} |
awk '{for(i=1; i<=20; i++) if ($i=="") $i="NA"; print $0}' | cut
-d " " -f 1-10,14-16 | sort | uniq | awk 'NR>0{split($13,a,"-");
$13=a[1]" "a[2];}1' | sed "s/ /\t/g" >
${i}.intergenic_SNPeff_horse.txt
echo "Done making ${i}_intergenic"
awk '{if ($14 != "intergenic_region") print $0;}' tmp4_${i} |
awk '{for(i=1; i<=26; i++) if ($i=="") $i="NA"; print $0}' | cut
-d " " -f 1-10,14-16,21-26 | sort | uniq | sed 's/ /\t/g' >
${i}.not_intergenic_SNPeff_horse.txt
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for int in {intergenic,not_intergenic}
do
echo "Searching for SNPEFF gene names ${i}.${int}"
awk '{print $13}' ${i}.${int}_SNPeff_horse.txt | grep
Equus | while read line
do
grep $line $zebra_gff3
done > tmp5_${i}_${int}
echo "Done finding SNPEFF gene names for ${i}.${int}"
sort tmp5_${i}_${int}| uniq | sed "s/;/\t/g" | sed 's/
/_/g' | sed 's/ID=//g' | awk '{print $9"\t"$12}' | sed
's/:_/\t/g' | sed 's/Note=Similar_to_//g' | sed 's/Note=//g' |
awk '{$2=toupper($2)}1'| sed 's/ /\t/g' | awk 'OFS="\t"{for(i=1;
i<=3; i++) if ($i=="") $i="NA"; print $0}' > tmp6_${i}_${int}
echo CHR_START$'\t'NA$'\t'NA >> tmp6_${i}_${int}
echo NA$'\t'NA$'\t'NA >> tmp6_${i}_${int}
join -1 13 -2 1 <(sort -k 13 ${i}.${int}_SNPeff_horse.txt)
<(sort -k 1 tmp6_${i}_${int}) | sed 's/ /\t/g' >
tmp7_${i}_${int}
done
rm ${i}.not_intergenic_SNPeff_horse.txt
mv tmp7_${i}_not_intergenic
${i}.not_intergenic_SNPeff_horse.txt
echo "Searching for second SNPEFF gene ${i}.intergenic"
awk '{print $14}' ${i}.intergenic_SNPeff_horse.txt | grep
Equus | while read line
do
grep $line $zebra_gff3
done | sort | uniq | sed 's/;/\t/g' | sed 's/ /_/g' | sed
's/ID=//g' | awk '{print $9"\t"$12}' | sed 's/:_/\t/g' | sed
's/Note=Similar_to_//g' | sed 's/Note=//g' | awk
'{$2=toupper($2)}1'| sed 's/ /\t/g' | awk -vOFS='\t' '{for(i=1;
i<=3; i++) if ($i=="") $i="NA"; print $0}' >
tmp8_${i}_intergenic
echo NA$'\t'NA$'\t'NA >> tmp8_${i}_intergenic
echo CHR_END$'\t'NA$'\t'NA >> tmp8_${i}_intergenic
echo "Done finding second SNPEFF gene ${i}.intergenic"
join -1 14 -2 1 <(sort -k 14 tmp7_${i}_intergenic) <(sort -k 1
tmp8_${i}_intergenic) | sed "s/ /\t/g" >
${i}.intergenic_SNPeff_horse.txt
rm TOPSNPS.ann.${i}.vcf
rm snpEff*
awk '{if ($8 ~ /RNA/) print $0;}'
${i}.not_intergenic_SNPeff_horse.txt | sed >
${i}.not_intergenic_SNPeff_horse_RNA.txt
awk '{if ($8 !~ /RNA/) print $0;}'
${i}.not_intergenic_SNPeff_horse.txt > tmp9_${i}
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rm ${i}.not_intergenic_SNPeff_horse.txt
mv tmp9_${i} ${i}.not_intergenic_SNPeff_horse.txt
awk '{if ($10 ~ /RNA/) print $0;}'
${i}.intergenic_SNPeff_horse.txt >
${i}.intergenic_SNPeff_horse_RNA.txt
awk '{if ($10 !~ /RNA/) print $0;}'
${i}.intergenic_SNPeff_horse.txt > tmp9_${i}
rm ${i}.intergenic_SNPeff_horse.txt
mv tmp9_${i} ${i}.intergenic_SNPeff_horse.txt
done
#remove extraneous files made for this process
rm *.bed
rm Equus_caballus*
rm tmp*
for i in {0,1000,5000,10000}
do
for int in {intergenic,not_intergenic}
do
awk -v num="$i" '{print num"\t"$0}'
$i.${int}_SNPeff_horse.txt > tmp
rm $i.${int}_SNPeff_horse.txt
mv tmp $i.${int}_SNPeff_horse.txt
rm tmp
cat $i.${int}_SNPeff_horse.txt >>
All.${int}_SNPeff_horse.txt
awk -v num="$i" '{print num"\t"$0}'
$i.${int}_SNPeff_horse_RNA.txt > tmp
rm $i.${int}_SNPeff_horse_RNA.txt
mv tmp $i.${int}_SNPeff_horse_RNA.txt
rm tmp
cat $i.${int}_SNPeff_horse_RNA.txt >>
All.${int}_SNPeff_horse_RNA.txt
done
done
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